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CORRESPONDENCE

Unusual Gastric Foreign
Bodies
To the editors. I read with great
interest the article by Kuzon and
colleagues on the management of
intragastric foreign bodies, which
appeared in the November 1988
issue (pages 413-417). It called to
mind a much earlier and similar
report by W.S. Halsted,1 which was
unusual in that his case was one of
the first in which the x-ray was
used to establish a preoperative
diagnosis.
Halsted supplies the following in
ventory of foreign objects removed
at the time of gastrotomy: 28 pieces
of chain that totalled 594 cm in
length, 99 nails of assorted sizes,
81 screws, tacks, pins, knife blades
and knife handles of assorted sizes
and 74 g of broken glass.
Like Kuzon’s patient, Halsted’s
suffered from a psychopathologic
condition. He is said to have made a
The Canadian Journal of Surgery
1867 Alta Vista Dr.
Ottawa, Ont. K1G 3Y6

grammes of glass extracted from the
stomach by gastrotomy. Recovery. Johns
Hopkins Hosp Rep 1900; 9: 1047-1059

living by swallowing foreign objects
for a price and, on the evening
preceding his hospital admission
and surgery, he apparently had
acted as entertainer at a party of
medical students. It seems that mat
ters got somewhat out of hand!
Halsted’s patient convalesced sat
isfactorily following operation al
though, since no follow-up informa
tion was provided, nothing is
known of the patient’s further di
etary practices.

Doctor or Mister?
To the editors. I read with interest
Eibel’s paper entitled “ Doctor or
Mister (the correct appellation of
British surgeons)” (Can J Surg
1988; 31: 452-453). The histori
cal background of the British sur
geon offers the clue to the custom
of using “ Mr.” to address a British
surgeon. I always understood that
“ Dr.” in British medical practice
was most frequently an honorary
term and that the university degree,
Bachelor of Medicine and Bachelor
of Surgery, entitles the majority of
British doctors to nothing other
than “ Mr.”. The term “Dr.” is
correct only for those who hold a
doctorate in medicine which is a
degree comparable to the D.Phil.

W.B. Firor, MD, FRCPC
Department o f Medicine.
University Hospital,
University o f Saskatchewan.
Saskatoon, Sask.
S7N 0X0

Reference
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H a l s t e d WS: A contribution to the sur
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CAIRNS

There is no doctorate in surgery.
Dr. Eibel is correct in pointing out
that the surgical degree is one of
Master of Surgery. The correct ap
pellation in this instance would be
“ Master” or as it is used more
commonly “ Mr.” .
It seems strange to me that any-

one in North America would regard
it as denigration to be addressed as
“ Mr.” . I can assure you that a
London surgeon would consider it a
denigration to be referred to as
“ Dr.” . These are curious customs
but have age-old precedents to sup
port them. They have a certain

charm even if they appear perverse
to others, rather like driving on the
left hand side of the road!
J.D. Cairns, MD, FACS, FRCSC
Ste. 215,
1333 Sheppard Ave. E,
Willowdale, Ont.
M 2J 1VI

BOOK REVIEWS
BIOLOGY OF LUNG CANCER. Diag
nosis and Treatment. Edited by Steven
T. Rosen, James L. Mulshine, Frank
Cuttitta and Paul G. Abrams. 362 pp.
Illust. Marcel Dekker, Inc., New York,
1988. $99.50 (US). ISBN 0-82477642-9.
The editors’ objective, stated in the
preface to this slim, well-produced vol
ume, is to produce a comprehensive
review of important recent advances in
our understanding of the basic cellular
and molecular biology of lung cancer.
This is a collection of papers on the
results obtained by the application of
new techniques in biochemical markers,
growth factors, oncogenes and im
munology to lung cancer. Although its
subtitle suggests a clinical orientation,
the text deals almost exclusively with
results from laboratory based research
on human tissue or cell lines. An up-todate review of antigens associated with
lung cancer and immunotherapy trials
is the only paper with a clinical orienta
tion. Thus, this book is directed to
specialists in lung cancer, particularly
those interested in current research,
which, by turning up a host of observa
tions, may give new insights appropri
ate for clinical testing.
The book includes papers by experts
in the field, with the largest representa
tion from the National Cancer Institute
in Washington. There is a concise open
ing chapter on current views of the
histologic patterns and the pathobiologic information they convey. This is
followed by descriptions of several bio
chemical markers, autocrine growth
factors and peptides, whose presence
may yield more precise categorization
of these heterogeneous tumours. An
84
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excellent overview of oncogenetics in
lung cancer is presented. Two chapters
describe the characterization of tumour
antigens in small-cell and non-small-cell
cancer. The final chapters cover the use
of monoclonal antitumour antibodies in
diagnosis and therapy, with and without
conjugation of the antibody with cyto
toxic drugs.
This book is up to date, well refer
enced and has clear diagrams and pho
tographs. There is little doubt that our
future understanding of lung cancer
will be based on much of the science
presented in this book. An overview of
the biologic background and future
directions as they relate to these papers
would have helped in placing this book
in perspective for non-experts and clini
cians in the field. The book certainly
deserves a place in libraries, institution
al or private, and will be a useful
reference work for all clinicians and
scientists involved with lung cancer.
D. Payne, MD, FRCPC
Department o f Radiation Oncology,
Princess Margaret Hospital,
500 Sherbourne St.,
Toronto, Ont.
M 4X 1K9

BREAST CANCER. Collaborative Man
agement. Edited by Jay K. Harness,
Harold A. Oberman, Allen S. Lichter,
Dorit D. Adler and Robert L. Cody.
390 pp. Illust. Lewis Publishers, Inc.,
Chelsea, Mich., 1988. $ 6 9 .9 5 (US).
ISBN 0-87371-106-8.
This is a collection of presentations
from a conference sponsored by the
University of Michigan Breast Cancer

Center after it had been in operation for
2 years. Most of the 30 authors are
from the centre. The book begins with
a good, albeit brief, review of the cur
rent biologic concept of the behaviour
of breast cancer. To manage a disease,
one should understand it. Unfortunate
ly, most of the other authors do not
appear to be familiar with the modern
concept of breast cancer and revert to
the Halstedian step-by-step view.
Although there is a neat, brief chap
ter describing the technique of segmen
tal mastectomy, axillary dissection is
not described. Indeed, in subsequent
chapters, a preference for total mastec
tomy is evident and breast-conserving
surgery without radiation is not even
considered.
Three chapters deal in some detail
with the dilemmas of the contralateral
breast, occult carcinomas and Paget’s
disease and management of breast can
cer in pregnancy in young women. In
this book, however, little or no personal
experience is offered, and since some
recent reports are not mentioned, the
recommendations are traditional and
unnecessarily aggressive.
One-third of the book is devoted to
the vital, often overlooked, psychosocial
aspects of breast cancer. Unfortunately,
most of these chapters read like propa
ganda, the authors trying to justify the
involvement of their disciplines. Most
Canadian surgeons recognize their re
sponsibility to deal with psychosocial
issues. Their ability to help their pa
tients will not be advanced by the advice
in this book that fatigue can be ma
naged by taking naps or going to bed
earlier, and the recommended aerobics
continued on page 108

HOW I DO IT

Stapled Bypass Procedure for
Unresectable Pancreatic Carcinoma
Fred L. Simon, MD, FRCSC, FACS; Paul H. Niloff, MD, FRCSC, FACS; Joan Darmstaedter, RN
ecause the frequency of pancre
atic carcinoma in the United
States is increasing and because, in
most cases, the tumour is unresect
able, there is an increasing demand
for efficient palliative procedures.
We describe one such procedure
which includes a biliary tract by
pass, a gastrojejunostomy and jejunojejunostomy. This procedure al

B

leviates symptoms and eliminates
the need for a subsequent operative
procedure to bypass a gastric outlet
obstruction.
The technique is rapid and effi
cient. We used it in 10 patients with
only one complication — a slight
twist of the bowel causing partial
obstruction in the distal jejunostomy.

From the Department o f Surgery, Doctors Hospital o f Lake Worth, and Department o f Surgery,
John F. Kennedy Memorial Hospital, Atlantis, Fla.
Accepted for publication July 11, 1988
Reprint requests to: Dr. F.L. Simon, 2887 Lake Worth Rd., Lake Worth, FL 33461, USA

Technique
The Auto Suture GIA PREMIUM
instrument (Auto Suture, Division
of U.S. Surgical Corp., Norwalk,
Conn.) is used to transect the jeju
num approximately 60 cm from the
ligament of Treitz (Fig. 1A). The
proximal staple line is resected and
the EEA stapler (Auto Suture) with
out the anvil is introduced into the
lumen of the jejunum, telescoping
bowel onto the instrument up to the
point of the gastric anastomosis
(Fig. IB). The antimesenteric bor
der of the jejunum is tented on the
EEA stapler and a pursestring su-

FIG. 1. Technique for stapled bypass of pancreatic tumour. It incorporates biliary tract bypass, gastrojejunostomy and
jejunojejunostomy.

CJS, VOL. 32, NO. 2, MARCH 1989

85

SIMON, ET AL.

ture is placed around the centre rod
which is in turn pushed through a
small stab wound at the apex of the
bowel. The pursestring suture is
tied and the anvil then attached to
the instrument.
The stomach is grasped at the

point of the intended anastomosis,
using the Auto Suture pursestring
instrument. A pursestring is insert
ed and the protruding tissue resect
ed (Fig. 1C). The EEA stapler anvil
is eased through the stomach wall
and the pursestring tied (Fig. ID).

The instrument is closed, fired and
then removed.
The jejunojejunostomy is per
formed in a similar fashion, approx
imately 15 cm from the gastric
anastomosis (Fig. IE). The cholecystojejunostom y or choledo-

An emerging
IN THE MANAGEMENT

mm

STAPLED BYPASS FOR PANCREATIC CANCER

chojejunostom y was performed
manually in our cases, although the
EEA or TA stapler was used previ
ously.1' 3 The final jejunojejunostomy is completed (Fig. IF) and the
jejunum closed with the Auto Su
ture TA 55 stapler (Fig. 1G).

References
1. L evi JU, Z epfa R. Hutson D, et al: A
rapid technique for biliary and duodenal
bypass in nonresectable pancreatic carci
noma. Arch Surg 1982; 117: 37 5 -3 7 6
2. T hompson E,

N acorney

DM:

Stapled

cholecystojejunostomy and gastrojejun
ostomy for the palliation o f unresectable pancreatic carcinoma. Am J Surg
1986; 151: 509-511
3. Mullin TJ. Damazo F, Dawe EJ: Cholecystoenteric anastomosis with the EEA
stapler for cancer o f the pancreas. Am J
Surg 1983; 145: 3 3 8 -3 4 2
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STATE OF THE ART

Endometrial Cancer
Mark E. Boyd, MD, FRCSC, FRCOG
Abdominal hysterectomy will cure cancer o f the endometrium confined to the body of
the uterus. If the tumour has spread beyond the uterus, adjuvant therapy w ill be
needed. The likelihood of such spread can be predicted from postoperative h istologic
examination of the uterus or discovered by surgical staging. Surgical staging does
not appear to be curative or to reduce the need for adjuvant therapy. Prognosis
depends on the grade and location of the tumour in the uterus and the extent of
invasion into the myometrium or beyond the uterus, and not on the removal of
occult metastases.

L’hysterectomie par voie abdominale est curative dans les cas de cancer de l'endometre
confine au corps de l’uterus. Quand la tumeur a envahi les autres tissus, une therapie
adjuvante est necessaire. La probability d’une telle dissemination peut etre prevue a
partir de l’examen histologique postoperatoire de l’uterus, ou decouverte lors d’une
chirurgie destinee a etablir le stade evolutif de la maladie. Ce type d’intervention ne paralt
pas avoir d’effet curatif et ne semble pas reduire la necessity d’une therapie adjuvante. Le
pronostic depend du stade et de la localisation de la tumeur dans 1’uterus, ainsi que de
l’importance de sa dissemination dans le myometre et hors de l’uterus, et non pas de
l’elimination de metastases occultes.

he current role of the general
gynecologist or surgeon in
managing the patient with gyneco
logic malignant disease is usually
limited to diagnosis and referral to a
gynecologic oncologist. This is be
cause invasive cancer of the cervix
is treated by radiation or radical
surgery and the general gynecolo
gist or surgeon does not have the
necessary expertise in selecting
cases, performing surgery and prov
iding the appropriate postoperative
care. Likewise with cancer of the
ovary, accurate staging and optimal
surgery will generally be more ef
fective when the patient is managed
by the subspecialist. Moreover,

T

\
P

►

»

:
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there is a need for experienced
supervision of subsequent chemo
therapy. Cancer of the vulva, a rare
condition, should be handled by a
gynecologist experienced in per
forming radical vulvectomy and in
deciding who needs other forms of
therapy.
In this paper I shall attempt to
determine if a similar attitude is
needed when dealing with cancer of
the endometrium, judged preoperatively as being confined to the body
of the uterus.
The rationale of treatment can
best be understood by knowing the
natural history of the disease, the
methods by which we can discover

From the Department o f Obstetrics and Gynecology, Royal Victoria Hospital, Montreal, PQ
Accepted fo r publication May 10, 1988
Reprint requests to: Dr. M.E. Boyd, Cynecologist-in-Chief, Royal Victoria Hospital, Women’s
Pavilion, 687 Pine Ave. W, Montreal, PQ H3A 1A1

its spread or stage and the accuracy
of these methods.

Natural History
Endometrial cancer, an adenocar
cinoma, occurs in postmenopausal
women who fall into one of two
distinct categories: a relatively
young (fifth or sixth decade), nulliparous, obese woman and an old
er, multiparous thin woman. Those
in the first group usually have a
well-differentiated tumour and a
good prognosis. The supposed eti
ology in this group is excessive
estrogen stimulation, either from
endogenous production or exoge
nous administration. In the second
group, the tumour is poorly differ
entiated and the prognosis poor. It
is suggested1 that the volume of
patients in this group is increasing
disproportionately.
Two histologic variations of the
adenocarcinoma pattern indicate a
poor prognosis: if malignant squa
mous elements are mixed with the
glandular elements (adenosquamous
carcinoma), the tumour is likely to
invade the myometrium deeply2 and
if the tumour is a papillary serous
carcinoma, endometrial in origin
but similar in behaviour to an ovari
an carcinoma, upper abdominal me
tastases will occur more frequently.3
The tumour is of three grades,
classified according to the degree of
differentiation. Just over 50% of
cases are grade 1 (well differentiat
ed).4 The grade of the tumour pre
dicts its capacity to invade. Thus,
there is deep invasion of the myo
metrium in only 12% of grade 1 and

►
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15% of grade 2 tumours, but in
46% of grade 3 tumours.5 The
incidence of lymph-node metastasis
parallels invasion; 3% of grade 1
tumours, 10% of grade 2 and 36%
of grade 3 have pelvic lymph-node
involvement.6 There are exceptions;
in one study,5 20% of well-differen
tiated adenocarcinomas showed
deep invasion of the myometrium,
with a high risk for lymph-node
involvement. If the myometrium is
not invaded, less than 1% of pa
tients have recurrent disease;3 if
invasion is deep, 42% of the tu
mours recur.7
The myometrial lymph channels
lead first to the nodes along the
iliac vessels and then to the aortic
nodes. If the pelvic nodes are invad
ed, 60% of the aortic nodes will be
involved, whereas if the pelvic
nodes are negative, only 1% of the
aortic nodes will have tumour de
posit.67 If the cervix or myometri
um in the region of the cervix is
involved, the possibility of paracer
vical glandular metastases is in
creased threefold.89 Lymph chan
nels also favour metastases to the
fallopian tubes and ovaries.
The peritoneal cavity is frequent
ly seeded with tumours cells early
in the course of the disease, pre
sumably through the open tubal
ostium; in stage I disease, cytologic
examination of the peritoneum
gives a positive result in 15% of
cases.1011 Paradoxically, it is unusu
al for peritoneal metastases to arise
from tumour that erodes through
the uterine serosa.
The frequent recurrences in the
vaginal wall were thought to result
from tumour implants at the time of
surgery. We now believe they are
manifestations of subclinical dis
ease, reaching the vagina through
paravaginal lymphatics and retro
grade vessel flow; in the latter in
stance, metastases are found char
acteristically on the anterior vaginal
wall just above the urethral orifice.
90
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Death is most often due to dis
tant hematogenous metastases, the
lungs and liver being the most
common sites.12

Staging
International Federation of Gyne
cology and Obstetrics (FIGO) stag
ing of corpus uteri (Table I) can be
determined from physical examina
tion, dilatation and curettage, and
histologic and routine radiologic
studies, but surgical staging is
more accurate. In 77% of tumours
diagnosed as stage I by the FIGO
method,13 subsequent surgical stag
ing will show one-third to be incor
rectly staged,14 as a result of unsus
pected cervical or adnexal invasion
or metastases to lymph nodes or
the peritoneal cavity. Especially
worrying is that in 11% of tumours
classified as stage I by the FIGO
method, nodal involvement has
been found,15 and these findings
have been substantiated in a num
ber of other studies.6-716
The diagnosis of FIGO stage II
disease depends on gross disease
being seen on the cervix preoperatively. If microscopic spread to the
cervix is found postoperatively the
disease is often restaged to surgical
stage II. Such patients have a nota
bly better prognosis than those
whose tumours are staged preoperatively by FIGO criteria alone and
this makes the credibility of pub
lished results questionable.17 The
improved results in stage II can also
be demonstrated with surgical re

staging in FIGO stage III disease.
Patients who have microscopic me
tastases to the ovary or fallopian
tube have a much better prognosis
than those who have gross disease
in the pelvis. Despite the difference
in prognosis, both groups are con
sidered to have stage III disease.18
The FIGO staging classification
has other serious deficiencies. Al
though the size of the uterus is of
little value in predicting out
come,19-20 the length of the uterus is
the criterion used in this classifica
tion for dividing stage I patients
into A and B groups. On the other
hand, tumour size, not part of the
FIGO classification has recently
been shown to be prognostically
important.21 When the tumour is
larger than 2 cm in diameter, 22%
of the patients were found to have
lymph-node metastases, increasing
to 40% when the entire endometrial
surface was involved.21 Sivridis and
colleagues22 reported that prognosis
is much worse if the adenocarcino
ma invades the lymphatic vascular
spaces of the uterus. Furthermore,
the FIGO classification does not
include important prognostic infor
mation such as tumour type and
size and depth of myometrial inva
sion. Finally, the grade and histo
logic type of tumour are frequently
found to be incorrect when the
whole of the uterus is examined
rather than isolated curettings.14

Diagnosis
An endometrial biopsy, usually

Table I. International Federation of Gynecology and Obstetrics Staging of Corpus Uteri
Stage/grade
Stage I
IA
IB
Grade 1
2
3
Stage II

Description
Cancer confined to corpus
Uterine cavity is < 8 cm long
Uterine cavity is > 8 cm long
Highly differentiated adenomatous carcinoma
Differentiated adenomatous carcinoma with partly solid areas
Solid or entirely undifferentiated carcinoma
Carcinoma has involved corpus uteri and cervix but has not extended outside
uterus
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done for postmenopausal bleeding,
identifies the disease. Endocervical
curettage can be misleading be
cause it may not identify extension
of the disease to the cervix,23 and
therefore therapy may not be ad
justed.24
In addition to routine preopera
tive investigation, computed axial
tomography or magnetic resonance
imaging have been suggested as a
means of delineating invasion of the
myometrium, cervix and lymph
nodes.25

Treatment

t

I

►
►

►

[

The treatment of stage I cancer
of the endometrium is total abdomi
nal hysterectomy and bilateral salpingo-oophorectomy. Preoperative
radiotherapy has fallen into dis
favour; it is of no proven value,
delays definitive therapy and ob
scures the findings of postoperative
histologic studies.
At laparotomy it is worthwhile to
collect peritoneal washings:1011 nor
mal saline (50 ml) is deposited in
the cul de sac then aspirated into a
container for examination by a cytopathologist.
When the disease is limited to the
uterus, selected series have shown
that hysterectomy provides a 98%
rate of cure, although the overall
survival is only 71.0%.2627 The pro
cedure is inadequate if the tumour
has spread beyond the uterus at the
time of surgery, thus putting con
temporary therapeutic practice into
question. Should the standard oper
ation be extended? If not, will the
patient’s future be compromised
and options for additional postoper
ative therapy limited? These ques
tions are pertinent, since modifica
tions such as radical hysterectomy,
pelvic or aortic node biopsy are
complex and best done by a gyneco
logic oncologist.
He will decide on the indication

for lymph-node biopsy before hys
terectomy (from histologic examina
tion of the curettings) and at the
time of surgery by determining the
site of disease, tumour size and
depth of myometrial invasion (by
bisecting the operative specimen
and examining a frozen section of
the uterine wall). If the nodes are
negative the patient can be spared
postoperative radiotherapy; if they
are positive, the radiotherapy can
be directed to certain areas, and
finally the need for chemotherapy
may be more quickly realized.
Arguments against this proce
dure are to me more persuasive.
Node dissection is done for prog
nostic purposes on patients who are
generally in poor health. No pro
spective trials have shown that sur
gical restaging is beneficial; it does
not alter the usual postoperative
adjuvant treatment and there is no
evidence that the removal of pelvic
or aortic nodes is therapeutic in
itself. The recommended procedure
is extensive and difficult. Pelvic
node biopsy involves the removal of
tissue lateral to the external iliac
arteries, medial to the common iliac
arteries and within the obturator
fossae. Aortic node biopsies consist
of removing tissue from the bifurca
tion of the aorta to the second part
of the duodenum; some authors28
recommend removal of additional
tissue lateral to the aorta up to the
level of the renal vessels.

evidence that overall survival is in
creased.29
Postoperative chemotherapy is
another option. The type to be used
is decided upon after evaluation of
the results of receptor studies on
the operative specimen. If the tu
mour is estrogen and progesterone
receptor-rich, it should respond to
progestational agents; if not, other
means of chemotherapy will be re
quired. Receptor content can be
predicted with reasonable accuracy
from tumour differentiation;30 the
more highly differentiated the tu
mour is, the greater the likelihood
of receptors being present.

Summary
If endometrial cancer is judged
clinically to be confined within the
body of the uterus, the indicated
treatment is abdominal hysterecto
my and bilateral salpingo-oophorectomy. The prognosis depends not
so much on adjuncts to this therapy
as on the surgical pathological find
ings. The need for supplementary
therapy postoperatively can be real
ized from histologic examination of
the uterus and cytologic examina
tion of the peritoneal fluid; lymphnode biopsy does not add notably to
this information. In contrast to
other gynecologic malignant dis
ease, there is no apparent indication
for immediate referral of patients
with stage I cancer of the endomet
rium to the gynecologic oncologist.

Postoperative Management
Indications for postoperative pel
vic radiotherapy in FIGO stage I
cancer of the endometrium relate to
surgical pathological findings. Inva
sion of the myometrium, disease in
the vicinity of the cervix and highgrade tumours suggest the need for
radiation. Postoperative radiothera
py decreases the frequency of vagi
nal recurrence, but there is little
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SESAP VI Question
Item 233

Thoracoabdominal aortic aneurysms are most often associated with
(A) medial degenerative disease
(B) aortic dissection
(C) median age < 50
(D) Ehlers-Danlos syndrome
(E) syphlitic aortitis
For the incomplete statement above, select the one completion that is
best of the five given.
For the critique of Item 233 see page 138.
(Reproduced by permission from SESAP VI Syllabus; Surgical Educa
tion and Self-Assessment Program No. 6. For enrolment in the Surgical
Education and Self-Assessment No. 6, please apply to the American
College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Perforated Benign Gastric Ulcer: the Case
for Simple Closure
Olin G. Thurston, MD, FRCSC
During the 12 years from 1975 to 1986 at University of Alberta Hospital,
Edmonton, 36 patients were found to have a perforated gastric ulcer. A review of
their operative treatment revealed that only one patient had a definitive gastric
resection despite reports in the literature recommending the procedure. This study
was undertaken to determine if simple closure was appropriate treatment for the
majority of these patients.
Even the enthusiasts of gastric resection would agree that advanced patient age,
serious underlying disease and delay in treatment are contraindications to the
procedure for perforated gastric ulcer. We found that 28 (78%) of the 36 patients
had one or more of these contraindications. Thus, the high-risk nature of the
patients presenting to our institution with perforated gastric ulcer explains the
frequent use of simple closure in these cases. The data from this study indicate that
the profile of patients presenting with perforated benign gastric ulcer needs to be
defined before generalizations regarding surgical treatment are made.

A l’Hopital universitaire d’Alberta d’Edmonton, sur une periode de 12 ans comprise
entre 1975 et 1986, 36 cas d’ulceres perfores de l’estomac ont ete diagnostiques.
L’etude des dossiers revele qu’un seul de ces patients a subi une resection gastrique
definitive, malgre les publications recommandant ce type d’intervention. Cette etude
fut entreprise dans le but de determiner si une fermeture simple constituait un
traitement approprie, dans la majorite des cas.
Meme ceux qui pronent la resection gastrique pour l’ulcere perfore concederont
que l’age avance d’un patient, la presence d’une maladie sous-jacente grave ou un
delai de traitement sont des contre-indications a cette operation. II a ete observe que
28 (78%) de nos 36 patients avaient au moins une de ces contre-indications. Le
risque eleve que presentaient les patients re?us dans notre etablissement souffrant
d’ulcere perfore, explique done l’utilisation frequente de la fermeture simple pour
traiter ce genre de cas. Les donnees de cette etude indiquent qu’il est necessaire de
bien definir le profil des patients admis dans un hopital pour ulcere gastrique benin
perfore, avant d’etablir une ligne de conduite generate quant au mode operatoire.

n 1937 Dr. Roscoe Graham of
Toronto published the results of
omental patch closure of perforated
duodenal ulcer in a series of 51
patients.1 His results — one early
death and one late death — were at
the time a quantum leap forward in
the management of this condition
and compare favourably to presentday results.2 Similar treatment was
logically instituted for perforated
gastric ulcers,3 the patients being
older and having more serious un
derlying diseases than those with
perforated duodenal ulcers. In the
1950s there was a trend toward
definitive treatment of perforated
duodenal ulcers in patients who
presented early and had no serious
underlying disease.4 Again a similar
attitude was extended toward pa
tients with perforated gastric ul
cers,56 but in these circumstances
the extension is illogical. In this
study I propose to show that be
cause of serious underlying disease
and delay in making the diagnosis,
the majority of these patients are
poor candidates for definitive ulcer
operations.
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Patients and Methods
During the 12-year period 1975
to 1986 inclusive, 36 patients seen
at the University of Alberta Hospital
had a recorded diagnosis of perfo
rated benign gastric ulcer. Their
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medical records were reviewed,
using the methods outlined by Feinstein and colleagues.7 Particular at
tention was paid to underlying med
ical diseases and to the time interval
from the onset of acute symptoms
to diagnosis and definitive treat
ment. The operative findings and
degree of contamination of the peri
toneal cavity were also noted since
they tend to confirm the time-inter
val data. For most patients in the
study the end point is death or
hospital discharge, although follow
up data collected by clinic visit,
telephone interview or report from
another physician was available in
14 of the patients. Where appropri
ate, tests of statistical significance,
Student’s unpaired f-test and the x2
test, were done using a HewlettPackard HP97 programmable cal
culator.

Findings
There were 21 women and 15
men who ranged in age from 35 to
94 years (mean 63 years). The mean
age of the women was 59 years and
the men 69 years, a significant (p <
0.05) difference. Serious underlying
medical problems, including ad
vanced malignant disease, chronic
obstructive pulmonary disease, car
diac, vascular and renal diseases,
were present in 23 patients (64%).
During hospitalization for another
illness, perforation occurred in six
patients (17%). Factors predispos
ing to gastric ulceration and perfo
T a b le 1. Operative Procedures for

Perforated Benign Gastric Ulcer
P rocedure

Simple closure +
omental patch
Closure about
gastrostomy
Draining of abscess
Billroth II gastrectomy
None
Total

N o. of p a tie n ts (% )

26 (72)
6 (1 7 )
2(6)
1 (3)
1 (3)
36

ration were noted as follows: 13
patients (36%) were taking steroids,
12 (33%) were taking nonsteroidal
anti-inflammatory drugs and 5
(14%) were alcohol abusers; 17
(47%) had a history of acid-peptic
disease. One or more of these fac
tors was present in 31 patients
( 86% ).
Sudden onset of abdominal pain
and rigidity occurred in about 67%
of the patients in this study. Diag
nosis was made and treatment car
ried out within 24 hours of the
onset of symptoms of perforation in
23 (64%). However, in 13 patients
(36%), the clinical picture was atypi
cal or the condition not recognized
immediately, so diagnosis and treat
ment were delayed; in 1 of these, a
perforated gastric ulcer was an un
expected finding at autopsy.
Thirty-five patients underwent an
operative procedure for the treat
ment of a perforated benign gastric
ulcer (Table I). Four patients, who
underwent suture closure or closure
about a gastrostomy, required reop
eration for reperforation (three pa
tients) or hemorrhage (one patient).
The hospital death rate for the
36 patients was 25% (9 patients)
and death was attributable to pul
monary failure and sepsis in most
cases. Although a number of varia
bles including age, sex and antibiot
ic use were studied in relation to
death, the only two that correlated
significantly were serious underly
ing disease (p < 0.02) and delay in
diagnosis and treatment beyond 24
hours (p < 0.01). Taking these two
factors together, we found that 27
of the 36 patients (75%) had one or
both factors operating against their
chances for survival.
Postoperative septic complica
tions occurred in 12 (34%) of the
35 patients operated on and were
related to a positive bacterial cul
ture from the peritoneal cavity at
the time of operation. They includ
ed intra-abdominal sepsis (six) pa

tients, wound infection (six) (includ
ing one clostridial infection) and
septicemia (two). Septic complica
tions occurred in 7 of 18 patients
who had a positive culture but in
none of the 6 who had a negative
culture (p < 0.05). Cultures were
not taken in 11 patients. There
were five deaths in the 18 patients
(28%) who had positive cultures and
one death in the 6 patients (17%)
who had negative cultures (p <
0.02) at the time of first operation.
Fourteen of the 27 who survived
the initial surgical procedure and
were discharged from hospital have
been followed up for periods rang
ing from 2 to 54 months (mean 14
months). Within this period two
patients died of causes unrelated to
gastric ulcer, two subsequently un
derwent gastrectomy (one died), two
are alive with symptomatic ulcers
and eight patients are alive and free
of ulcer disease, including the one
who underwent gastrectomy.

Discussion
Only one patient in our study had
a gastric resection as the emergen
cy treatment for perforated benign
gastric ulcer while most had simple
closure of the perforation. There
has been no policy for or against
either treatment at our institution;
the choice was left to the attending
surgeon. Records revealed that 75%
of the patients had other serious
underlying medical conditions or
there was a delay in diagnosis be
yond 24 hours after the estimated
time of perforation. If patients over
80 years of age are added to this
list, then only 8 of 36 patients
could be considered candidates for
gastric resection, even by advocates
of this treatment. The low numbers
of patients suitable for gastric re
section and the lack of evidence
that acute perforations will require
a definitive ulcer operation likely
CJS, VOL. 32, NO. 2, MARCH 1989
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explains the low incidence of gastric
resection in our series and others in
the literature.89
A reason for proposing gastric
resection as treatment is the diffi
culty in differentiating benign from
malignant gastric ulcers when they
are perforated. This indication for
resection is negated by follow-up
endoscopy in all patients with perfo
rated gastric ulcers. In addition,
patients with perforated gastric car
cinoma have a poor prognosis re
gardless of treatment.8
The hospital death rate (25%) in
this series is in the range reported
by others.10 When compared with
series reported in 19574 and 1973,3
it has not changed appreciably. Pro
ponents of gastric resection, McGee
and Sawyers,6 reported a 29% death
rate with simple closure and a 15%
rate for gastric resection. However,
this difference is not significant. It
is suggested that for perforated
duodenal ulcer, survival is deter
mined by the state of the patient on
admission rather than the choice of
operation;211 this may apply equally
to perforated gastric ulcer.
In this study, a positive culture
from a sample taken from the peri
toneal cavity at the time of initial
surgery was a significant finding
with regard to postoperative septic
complications and death. The or
ganisms most frequently cultured
were non-hemolytic streptococci,
Streptococcus viridans and yeast
like organisms, mostly Candida.12
Various anaerobic organisms were
also isolated.13 Bacteria associated
with gastroduodenal perforations
are not as well defined as in lower
intestinal perforations where Bacteroides, coliform organisms and
Clostridia form three well-defined
groups against which antimicrobial
therapy can be directed. Gas
troduodenal perforations may be
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sterile early on or later present a
bewildering array of weakly patho
genic organisms. The situation is
reminiscent of that existing with
lower intestinal perforations before
the importance of the gram-nega
tive anaerobes, mainly Bacteroides
sp., was appreciated. At present, it
is difficult to predict which organ
isms will emerge as pathogens in a
patient with perforated gastric or
duodenal ulcer,14 and thus it is
difficult to select an antibiotic or
suitable combination until septic
complications occur. The value of
cultures from the peritoneal cavity
at the time of surgery for perforated
gastric ulcer appears to be in identi
fying the patients likely to suffer
septic complications rather than
identifying the likely pathogens.

Conclusions
In spite of recent reports recom
mending gastric resection as the
treatment of choice for patients
with perforated gastric ulcers, there
is a lack of good data supporting
this recommendation. When the re
sults of a simple procedure are
roughly equivalent to those of a
more complex one, surgeons work
ing in an emergency situation with
high-risk patients will choose the
simple procedure.
Uncertainty about the bacteria
associated with gastric perforations
is a final reason for choosing simple
closure over gastric resection. At
operation, the peritonitis may be
chemical or chemical and septic.
Organisms of doubtful pathogenici
ty may be cultured from the perito
neal cavity. These organisms may
or may not be responsible for future
septic complications, making antibi
otic use and choice somewhat of a
lottery. In this setting, simple clo

sure of a perforated gastric ulcer
becomes an attractive procedure re
gardless of the age or medical con
dition of the patient.
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Biliary Tract Reconstruction in Liver
Transplantation
William J. Wall, MD, FRCSC; David R. Grant, MD, FRCSC; Richard E. Mimeault, MD, FRCSC;
David P. Girvan, MD, FACS, FRCSC; John H. Duff, MD, FRCSC
Refinements in biliary tract reconstruction and the frequent use of cholangiography
have produced a marked decline in the number of deaths from biliary complications
after liver transplantation. The authors’ method of reconstruction differs from those
of others in that it employs no stents or T tubes and retains the donor gallbladder,
allowing access to the biliary tract for radiologic purposes in the post-transplant
period.
In a series of 161 consecutive liver transplants, the frequency of biliary
complications was 13.6% (15 anastomotic and 7 gallbladder-related). Of three deaths
that occurred in patients with biliary complications, one was due to the complication
itself. A Roux-en-Y reconstruction with anastomosis to the donor duct was
associated with the lowest anastomotic complication rate (2.2%). Upper abdominal
surgery before transplantation, especially shunting, was a major risk factor for
biliary complications.

Les ameliorations apportees a la reconstruction des voies biliaires et l’utilisation
frequente de la cholangiographie ont entraine une baisse marquee du nombre de deces
post-transplantation hepatiques, dus a des complications biliaires. La methode de
reconstruction preconisee par les auteurs differe des autre en ce qu’elle n’utilise ni
manchon d’anastomose, ni tube en T, et qu’elle conserve la vesicule biliaire du donneur,
ce qui permet l’acces aux voies biliaires pour fins de radiographie durant la periode
post-transplantation.
Lors d’une serie de 161 greffes hepatiques consecutives, la frequence des
complications biliaires fut de 13.6% (15 au niveau des anastomoses et 7 au niveau de
la vesicule). Sur trois deces survenus chez des patients souffrant de complications
biliaires, une etait due a la complication meme. Une reconstruction de Roux-en-Y
avec anastomose au choledoque du donneur fut associee au plus faible taux de
complications anastomotiques (2.2%). Les operations abdominale hautes, surtout les
interventions de derivation, ont represente un facteur de risque important de
complication biliaire.
iver transplantation prior to the
late 1970s, at the time the liver
transplant program was beginning
in London, Ont., was associated
with a distressingly high morbi-

L

dity and mortality attributable to
complications of the biliary recon
struction.12 Almost one-third of
liver transplant recipients had bili
ary tract complications, which were
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directly or indirectly the cause of
nearly half of the deaths.12 Since
then, deficient methods of recon
struction have been recognized and
abandoned, and refinements in op
erative technique have reduced the
frequency of biliary complications
to 12% to 14%,34 although they
remain the most common technical
complication of liver transplanta
tion. Our preferred method of bili
ary drainage differs from those of
other centres. It employs no T
tubes or stents and uses the donor
gallbladder as an external cholecystostomy for radiologic access to the
biliary tree.5 We have reviewed our
experience to determine the inci
dence, type and outcome of biliary
complications in liver transplanta
tion.

Patients and Methods
We reviewed the first 161 or
thotopic liver transplants performed
in 145 recipients (92 females, 53
males) at University Hospital and
Children’s Hospital of Western On
tario; 14 patients received two
transplants and 1 received three.
The ages of the patients ranged
from 8 months to 68 years.
In 113 of the recipients, endstage cirrhosis (e.g., primary biliary
cirrhosis, cirrhosis from chronic ac
tive hepatitis, biliary atresia) was
the indication for transplantation.
In the remainder, acute liver failure,
sclerosing cholangitis, cholestatic
syndromes, neonatal giant cell hep
atitis, cancer and glycogen storage
disease were the indications. Before
transplantation, 61 (42%) of the
CJS, VOL. 32, NO. 2, MARCH 1989
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recipients had undergone upper ab
dominal surgery, including por
tosystemic shunting (23 patients),
biliary tract surgery (23), laparoto
my and liver biopsy (9), splenecto
my (5) and gastrectomy (1).
The general aspects of the recipi
ent operation have been described
elsewhere.6 Three types of biliary
drainage were used: an end-to-end
duct-to-duct anastomosis (D-D), a
Roux-en-Y jejunal loop to the end
of the donor duct (R-D), or a
Roux-en-Y jejunal loop to the
donor gallbladder (R-GB). The pre
ferred method was a D-D anasto
mosis if there was no disease of the
recipient duct. When the recipient
duct was abnormal or unsuitable, as
in cases of sclerosing cholangitis,
an R-D reconstruction was used.
An R-GB anastomosis was per
formed infrequently. The anastomo
ses were single-layer, using inter
rupted full-thickness bites with ap
proximation of mucosal layers.
Posterior-wall sutures were placed
and tied first with knots on the
inside. Anterior-wall sutures were

knotted on the outside. Sutures
were 5-0 polydioxanone (PDS; Ethicon Sutures, Peterborough, Ont.) in
adults and 6-0 or 7-0 PDS in chil
dren. Anastomotic stents and T
tubes were not used.
In 139 transplants, the donor
gallbladder was used as an external
cholecystostomy with either a no.
12 Malecot or no. 10 Foley catheter
exiting from the fundus of the
gallbladder (Fig. 1). In the remain
ing 22 transplants, low entrance of
the cystic duct resulted in its tran
section at the site of division of the
common duct in the donor, and
therefore the gallbladder was re
moved. The gallbladder catheter
was left open to straight drainage
for 1 week postoperatively, at the
end of which the first of several
cholangiograms over the ensuing
weeks was obtained. If the anasto
mosis was satisfactory, the gallblad
der catheter was clamped. Repeat
cholangiography was the first inves
tigation performed if and when tests
of liver function were abnormal.
The gallbladder catheters were re
moved between 6 and 12 weeks
after transplantation.
There were 125 D-D reconstruc
tions, 33 primary R-D reconstruc
tions and 3 R-GB anastomoses. In
12 patients, a failed reconstruction
was revised to an R-D anastomosis,
bringing the total R-D anastomoses
to 45. In the group of 16 retrans
plants, there were 12 D-D anasto
moses and 4 R-D reconstructions.
Statistical analysis was done using
Fisher’s exact test. The average

follow-up period was 17.2 months
(range from 3 months to 5.8 years).

Results
There were 22 biliary tract com
plications in the 161 transplants, an
overall incidence of 13.6%; 15 were
anastomotic complications and 7
were complications related to the
gallbladder.
The anastomotic complications
are summarized in Table I. The 11
obstructions became evident at 3
days, 2, 4, 5, 6 and 7 weeks and 3,
5, 7, 17 and 18 months after trans
plantation. Nine obstructions were
revised to R-D anastomoses (in
cluding 1 primary R-D anastomosis
which was redone); two strictures
were dilated percutaneously 3 and 4
weeks after transplantation and
both of these patients had normal
liver function at 13 and 21 months’
follow-up. The four anastomotic
leaks were all in D-D reconstruc
tions; they occurred at 5, 20 and 26
days and 3 months respectively.
Three were revised to R-D anasto
moses and one was managed by
insertion of a T tube.
Of the seven gallbladder compli
cations, four were leaks at the
cholecystostomy tube exit site. One
leak occurred 5 weeks after trans
plantation when the gallbladder
catheter was accidentally dislodged;
the other three leaks occurred when
the catheters were removed at 6, 9
and 9 weeks after transplantation.
Bile peritonitis developed within
hours of catheter removal in each

Table 1. Biliary Anastomotic Complications in 161 Liver Transplants
Type of reconstruction
Complications
Obstruction
Bile leak

FIG. 1. Post-transplant cholangiogram
of duct-to-duct anastomosis (white ar
row) via gallbladder catheter. Shadow
of catheter is visible in lumen of gall
bladder (black arrow).
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Totals

D-D
(n = 125)

R-D
(n = 45)*

RGB
(n = 3)

9
4

1
0

1
0

13(10.4%)

1 (2.2%)

1 (33%)

‘ Includes 33 primary R-D anastomoses and 12 R-D revisions of failed primary reconstructions.
D-D = end-to-end, duct-to-duct anastomosis, R-D = Roux-en-Y jejunal loop to end of donor duct,
R-GB = Roux-en-Y jejunal loop to donor gallbladder.

A

BILIARY RECONSTRUCTION AND LIVER TRANSPLANTATION

case and the patients required lapa
rotomy and reinsertion of the cathe
ter. After the cluster of gallbladder
leaks, we decided to delay catheter
removal until 3 months after trans
plantation. Since we adopted this
policy there have been no leaks.
One patient had sudden, unex
plained bleeding from the gallblad
der 5 weeks after transplantation
and required emergency cholecys
tectomy. Two patients who had
cholelithiasis 17 and 23 months
respectively after transplantation
were managed by cholecystectomy.
A greater number of patients
with anastomotic biliary complica
tions had undergone upper abdomi
nal surgery previously (Table II).
Only 36.9% of patients without bili
ary complications had previously
undergone abdominal operations,
but 86.7% of patients with failed
biliary anastomoses had had a previ
ous operation, most commonly a
shunt (six) or biliary tract operation
(three). This difference was highly
significant (p < 0.003). The six
shunts included two mesocaval
shunts, two Warren shunts, one
portacaval and one splenorenal
shunt. Thus, of the 23 recipients
who had a portosystemic shunt of
some variety before transplantation,
6 (26%) suffered a biliary complica
tion after.
Of the 22 patients who had bili
ary complications, 19 survived and
are alive. Two of the three deaths
occurred in patients who had anas
tomotic complications. One patient,
who had revision of a strictured DD anastomosis, died of sepsis 2*/2
Table II

P r e v io u s S u r g e r y in L iv e r

T r a n s p la n t R e c ip ie n t s W it h a n d W it h o u t
B ilia r y C o m p lic a t io n s

Surgery

W ithout
With
com plications complications
(n = 130)
(n = 15)

S h u n tin g

17

B ilia ry t r a c t

20

3

O th e r

11

4

T o t a ls , n o . ( % )

4 8 (3 6 .9 )

6

1 3 (8 6 .7 )

months after a subsequent retrans
plant for chronic rejection. The sec
ond death occurred in a child who
required revision of an obstructed
R-GB anastomosis. Hepatic artery
thrombosis occurred, requiring re
transplantation, but the second
graft failed because of recurrent
hepatic artery thrombosis. Neither
of these deaths was related to the
biliary complication. The third
death occurred in the patient who
had bile peritonitis after the gall
bladder catheter became accidental
ly dislodged. Candida septicemia re
sulted in death 10 weeks after
transplantation. The bile peritonitis
was believed to be a major contrib
uting factor in this patient’s death.
Thus, the death rate in patients
with biliary complications was
13.6% (3 of 22), but in only 1
patient was the biliary complication
related to the death.
Of the 145 recipients, 112
(77.2%) were alive from 3 months
to 5.8 years after transplantation.
One- and 5-year actuarial survival
rates were 74.8% and 73.2% respec
tively.

Discussion
The catastrophic complications of
failed biliary reconstruction that
plagued liver transplantation in the
past resulted from their frequent
occurrence plus failure to diagnose
accurately and treat promptly the
complications when they occurred.
Better methods of reconstruction
and the use of cholangiography to
assess accurately the integrity of
biliary drainage have reduced the
morbidity and mortality.3’7-8 Death
due primarily to biliary complica
tions is now uncommon.4
The most popular current meth
ods of reconstruction are the D-D
or R-D anastomosis, performed
over a T tube or stent, combined
with removal of the donor gallblad
der.34 The long tradition of using T

tubes and stents in bile-duct repairs
in non-transplant surgery910 has
undoubtedly had a positive influ
ence on their use in liver transplan
tation; however, convincing evi
dence of a beneficial effect on heal
ing of biliary anastomoses is lack
ing. There are disadvantages to
their use in liver transplantation.
They may obstruct the lumen of
smaller ducts, leakage from T-tube
exit sites has been fairly common
and retained stents have caused
obstruction and sometimes needed
reoperation for removal.3811 The
choledochotomy and sutures re
quired for inserting and securing T
tubes or stents may damage the
tenuous blood supply to the bile
duct.12 For these reasons we have
avoided their use; instead we retain
the donor gallbladder whenever
possible and employ a catheter
cholecystostomy for radiologic ac
cess to the biliary tree postoperatively. Cholangiography plays an
important role in detecting prob
lems at the biliary anastomosis,
thereby allowing corrective proce
dures before either the graft or the
patient’s life becomes jeopardized
from biliary complications. In addi
tion, cholangiography has helped to
resolve the differential diagnosis of
jaundice in the post-transplant peri
od, in particular to separate biliary
obstruction from rejection.
The 10% incidence of anastomot
ic complications in D-D reconstruc
tions and the superior results ob
tained with R-D reconstructions in
this series are similar to results
reported by others.3413 The good
blood supply to the Roux loop plus
its bulk promote good healing. De
sirable features of a D-D recon
struction are that it is physiologic
and is relatively quick and easy to
perform. However, the lower mor
bidity with R-D reconstruction is
noteworthy and some surgeons ad
vocate its routine use.13 Revision of
a failed D-D anastomosis to an R CJS, VOL. 32, NO. 2, MARCH 1989
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D reconstruction is effective, al
though some early D-D strictures
can be dilated with good long-term
results, as seen in two patients in
this series. We have no experience
with the gallbladder conduit tech
nique described by Caine;14 in situa
tions in which this might be useful
we have opted for an R-D recon
struction.
The role of previous surgery,
especially shunting, as a risk factor
for the development of biliary anas
tomotic complications was an im
portant finding in our series and it
has implications for selecting the
type of drainage procedure to be
used. Previous biliary surgery or
procedures that dissect the struc
tures of the portal triad (e.g., por
tacaval shunts) logically increase
the anastomotic complication rate
because of subsequent scarring in
the porta hepatis, ischemia of the
duct and a technically more difficult
anastomosis. The increased inci
dence of biliary complications is not
as easy to explain when the previ
ous surgery has been a shunt re
mote from the porta hepatis (e.g.,
Warren or mesocaval shunt). A
practical consideration in this situa
tion is that the effort required for
the transplant surgery, augmented
by the extra work and difficulty in
dealing with the shunt, may result
in operator fatigue, which may
compromise the quality of the bili
ary reconstruction at the end of a 6or 7-hour operation. Because of the
lower incidence of complications
with R-D reconstruction it may be
appropriate to use this type of
drainage for these higher risk pa
tients even though it makes the
operation longer.
Leakage from the gallbladder
catheter exit site should be avoid
able. The paucity of adhesions
around the cholecystostomy has
been a notable feature in those
patients who required laparotomy
for bile peritonitis after catheter
100
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removal. Steroids undoubtedly have
had an effect and we no longer
remove the catheter until 3 months
or more after the transplant and
when the daily steroid dose is less
than 0.2 m g/kg body weight.
The long-term frequency of
cholelithiasis in the donor gallblad
der remains to be determined. Most
recipients receive a relatively young
donor organ, which in itself may
delay the occurrence of cholelithia
sis. Engel and associates15 studied a
small number of our recipients and
assessed gallbladder function as
measured by fasting gallbladder vol
umes, rate of gallbladder emptying
and the release of cholecystokinin.
Patients with transplanted gallblad
ders had results similar to agematched normal controls, so stasis
does not appear to be characteristic
of the transplanted gallbladder.
Nevertheless, it is uncertain how
problematic cholelithiasis might be
come in these recipients over the
long term, and ultrasonography of
the biliary tract has become part of
our annual follow-up. It is impor
tant to irrigate the donor gallblad
der and biliary tree gently but thor
oughly at the time the liver is
removed and again in the recipient
before constructing the cholecys
tostomy, to remove any blood clot
or debris that could act as a nidus
for stone formation.
The state of malnutrition of liver
recipients at the time of transplan
tation magnifies the potential for
poor healing associated with im
munosuppressive therapy. These
factors underline the importance of
the accepted principles of good
blood supply, absence of local infec
tion, lack of tension and sound
technique that are prerequisites for
satisfactory healing of any anasto
mosis. The good results with R-D
reconstruction without T tubes or
stents in our patients who were at
special risk for poor healing may
merit a reappraisal of the use of

tubes and stents in non-transplant
biliary reconstructive surgery.
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Biologic and Structural Evaluation of 80
Surgically Excised Human Umbilical Vein
Grafts
Stephane Julien, MD; Francis Gill, BSc; Robert Guidoin, PhD; Randy Guzman, MD;
Jamal Charara, PhD; Paul-Emile Roy, MD; Michel Marois, MD; Gilles Laroche, MD, FACS, FRCSC;*
Michel Batt, MD;t Paul Roy, MD;* Jean-Michel Serise;t Denis Marois, MD, FACS, FRCSC*
Human umbilical vein is a valuable alternative to autogenous saphenous vein in
lower-limb revascularization. However, the long-term patency is not as good. To
understand better the reasons for this, the authors studied the biologic and
structural changes occurring in 80 segments of human umbilical vein (HUV) grafts
excised from 70 patients. Morphologic, histologic and scanning electron microscopy
examinations were performed on each specimen. It was noted that increasing
duration of implantation was associated with greater encapsulation and less
surrounding inflammatory reaction. Twenty-six percent of clinically noninfected
grafts were found to harbour bacteria. Bacteremic colonization was often in the folds
of the luminal surface. As a result of these findings, the authors emphasize the need
for complete excision of clinically infected grafts. Anastomoses between HUV
segments are discouraged because they are associated with a high frequency of
infection and a corresponding decrease in duration of implantation. Delamination of
the wall was common, and such sites may represent areas at risk for further
degradation. Continued surveillance of the biologic and structural changes
occurring in excised grafts remains an im portant method in increasing our
understanding of the evolutive complications of HUV grafts.

:

La veine ombilicale humaine constitue une bonne alternative a la veine saphene autogene,
pour la revascularisation des membres inferieurs. Toutefois, sa permeabilite a long terme
n’est pas aussi bonne. Pour mieux comprendre les raisons de ceci, les auteurs ont etudie
les changements biologiques et structuraux qui sont survenus dans 80 segments de
greffons de veine ombilicale humaine (VOH) qui avaient ete excises chez 70 patients. Des
examens morphologiques, histologiques et de microscopie electronique ont ete pratiques
sur chaque echantillon. On a observe qu’avec [’augmentation de la duree de la greffe etait
associee une plus grande encapsulation et une reaction inflammatoire moins importante.
Vingt-six pourcent des greffons cliniquement non infectes abritaient des bacteries. La
colonisation bacterienne apparaissaient souvent dans les replis de la surface luminale.
Consequence de cette observation, les auteurs soulignent la necessite d’exciser
completement les greffons cliniquement infectes. Les anastomoses entre des segments de
VOH ne sont pas recommandees, car elles sont reliees a un fort taux d’infections et a une
baisse correspondante de la duree des greffes. Une delamination de la paroi etait
frequente, ce qui pourrait representer une region susceptible de developper une
deterioration plus poussee. La poursuite d’une etroite surveillance des changements
biologiques et structuraux qui surviennent dans les greffons excises, constitue un moyen
important d’ameliorer nos connaissances des complications evolutives des greffons de
VOH.
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utogenous saphenous vein is
still the graft material of choice
for lower limb revascularization.1
However, this vein is not always

►

ical vein (HUV) was found to be a
valuable alternative for femoropopliteal and femorodistal bypasses23
and for the creation of arteriove
nous fistulas.45 The results of its
use in these situations are compara
ble to those obtained with expanded
polytetrafluoroethylene in above
knee bypasses and are better than
those reported for below-knee by
passes.6
Because the long-term patency of
HUV grafts is inferior to that of
autogenous saphenous vein, Dardik
and colleagues7 have recommended
limiting their use to patients with a
deficient or absent autologous sa
phenous vein and a limited life

available: it may be inadequate, dis
eased or absent because of previous
vascular surgery.1 In the search for
other blood conduits, human umbil
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expectancy. Several groups89 have
questioned the long-term fate of
HUV grafts in vascular surgery be
cause of dilatation observed in pa
tent grafts. To understand better
the in-vivo biostability of chemically
processed HUV grafts, we have
analysed, by morphologic, histolog
ic and scanning electron microscopy
examinations, 80 surgically excised
grafts.

Materials and Methods
The 80 HUV grafts were surgi
cally excised at eight different cen
tres in Canada and five in France
from 70 patients (49 men, 16
women and 5 of unknown sex). The
mean age of the patients at implan
tation was 67 years (range from 29
to 90 years). The mean duration of
implantation was 9.7 months (range
from 1 day to 78 months). Of the
80 grafts, 78 were used for revascu
larization of the lower limbs; 1 was
implanted as an arteriovenous fistu
la for plasmapheresis in a
29-year-old woman with Behcet’s
syndrome1011 and 1 was used to
create an axilloaxillary bypass.
After excision, the grafts were
opened longitudinally, carefully
rinsed with heparinized saline, fixed
in a buffered solution of 1.5% glutaraldehyde and shipped immediate
ly to the Laboratoire d’Analyses
Fonctionnelles at the Hopital StFranqois d’Assise in Quebec City.
They were photographed and exam
ined, using a Tessovar macro
photography optical system (Carl
Zeiss, Oberkochen, Germany). Rep
resentative areas were selected for
pathological studies. Each area was
divided into three specimens. The
first was post-fixed in a Perfix solu
tion (Fisher Scientific, Montreal,
PQ), dehydrated with ethanol and
clarified with toluene before being
mounted in paraffin. Sections 4 jum
thick were stained in the following
102
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order for viewing by light microsco
py: Weigert’s, Masson’s trichrome,
Brenn and Brown and Dahl stains.
The second specimen was frozen in
a bath of isopentane at —150°C.
The frozen tissue was sectioned in a
cryostat and stained with oil red 0
for neutral lipid (Sudan IV). The
third specimen was post-fixed in
thiocarbohydrazide and osmium tetroxide for scanning electron mi
croscopy. In this case, dehydration
was obtained by immersing the
specimen in a series of ethanol
solutions of increasing concentra
tions, culminating in pure ethanol,
followed by critical-point drying
with liquid carbon dioxide as the
transfer medium. The specimen was
then coated with gold-palladium
and examined in a JSM 35CF scan
ning electron microscope (Soquelec,
Montreal PQ) at 15 to 20 kV of
accelerating voltage.

Results
Clinical Observations

The indications for implantation
are set forth in Table I. Longer
duration of implantation seemed to

be associated with less severe symp
toms of arterial disease.
Thrombosis was the major indi
cation for reoperation (Table II);
74% of grafts were removed after a
mean implantation period of 8
months because of thrombosis.
True aneurysm formation appeared
to be a late (mean 3 years) and
unusual (four cases) complication.
One false aneurysm developed at
the anastomotic site between two
segments of HUV (Figs. 1 and 2).
The site of implantation also af
fected the duration of patency of
the graft (Table III). The duration
of implantation was 50% longer for
above-knee grafts than below-knee
grafts.

Macroscopic Observations

About one-third of the grafts had
irregular wall thickness. Most had
folds on the luminal surface, about
one-third being deep folds. The lu
minal surface was often covered
with thrombotic debris, particularly
at anastomotic sites.
The external capsules of the ex
cised grafts were classified using
four degrees of encapsulation:

Table 1. Indications for Surgery
Mean age
of patients,
Indication

yr

No. of
prostheses

Claudication
Rest pain
Limb salvage
Aneurysm
Arteriovenous fistula
Unknown

58
65
76
50
29
65

10
35
23
1
1
10

Mean duration
of implantation,
mo
19
8
8
2
4
11

Table II. Indications for Reoperation*
Duration of implantation, mo
Indication

<1

1-3

4 -1 2

>12

Unknown

Total

Mean

Thrombosis
Infection
Run-off degradation
Aneurysm
False aneurysm
Stenosis

21
4
4
0
0
0

7
6
1
1
0
0

16
9
4
1
0
0

9
1
2
2
2
1

6
1
1
0
0
1

59
21
12
4
2
2

8
5
8
36
17
19

'Som e prostheses were excised for more than one reason.
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none, thin fibrous capsule, interme
diate fibrous capsule and thick fi
brous capsule. We found that high-

er degrees of encapsulation were
associated with increasing duration
of implantation (Table IV).
The relation between duration of
implantation, infection and the
number of HUV segments is shown
in Table V. The duration of implan
tation decreased as the number of
segments anastomosed and the per
centage of grafts excised for infec
tion increased.

Microscopic Analysis

The evaluation of lipid uptake by
Table III. Sites of Implantation

Site

FIG. 1. Angiogram showing false an
eurysm (arrow) at suture line of
human umbilical vein (HUV) graft used
for femorofemoral bypass in 72-yearold patient with limb-threatening isch
emia. Prosthesis was in place for 12
months.

Mean duration
No. of of implantation,
prostheses
mo

Femoropopliteal
Above knee
Below knee
Unknown
Femorodistal
Other
Unknown

40
10
24
6
27
4
9

13
21
11
7
5
6
7

►

between prosthesis (P) and host artery (A).
i

Table IV. Effect of Duration of Implantation on Degree of Encapsulation

►
Degree of
encapsulation
►

►

None
Thin capsule
Intermediate capsule
Thick capsule

No. of
prostheses
(n = 65)

Mean
duration of
implantation, mo

28
16
17
4

1
3
8
24

the graft wall only by Sudan IV
staining was not 100% reliable be
cause of technical artifacts. Depos
its of cholesterol were observed by
scanning electron microscopy in 29
prostheses. The accumulation was
subjectively classified as follows:
none, minimal, moderate and large.
Table VI shows a relation between
the extent of cholesterol accumula
tion and presence or absence of
dyslipidemia. Patients who had dyslipidemia did not appear to accumu
late cholesterol on the surfaces of
their prosthesis compared with
those without dyslipidemia. The
patency of the graft did not seem to
be influenced by cholesterol deposi
tion.
Bacteria were observed histologi
cally and by scanning electron mi
croscopy in 38 grafts (Table VII). In
two cases, the prosthesis was in
fected clinically, but no bacteria
were noted. In addition, 26% of
prostheses were found to harbour
bacteria while no infection was
noted clinically. Sometimes the bacteremic colonization was limited to
the luminal surface of the prosthe
sis (Figs. 3 and 4); in other cases
the wall of the graft was invaded
(Fig. 5). Folds on the luminal sur
face of the graft may also offer a
preferred site for bacteremic coloni
zation (Figs. 6 and 7).
Inflammatory reactions were
common, occurring in 26 cases.
These reactions were subjectively
classified as follows: no inflammato
ry reaction, limited, intermediate
and intense inflammatory reaction.
Such reactions were often seen in
clinically infected prostheses. When
this reaction was intense, the dura
tion of implantation was greatly
reduced. An example of an inflam
matory reaction is presented in Fig.
8. This reaction was classified as
moderate on our scale.
Delamination occurs frequently
with HUV grafts (Fig. 9). We could
not demonstrate any relation beCJS, VOL. 32, NO. 2, MARCH 1989
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tween the extent of delamination
and bacteremic colonization, al
though delaminated sites would
seem to be ideal for bacterial
growth. They represent, at the very
least, potential sites for further deg
radation.

individual patient’s metabolism.15
We found that patients suffering
from dyslipidemia are less likely to
have cholesterol deposition on the
luminal surface. Further investiga
tions in this area need to be done in
order to understand the effect of
lipid metabolism on the patency of
these grafts. Lipid uptake is diffi

cult to assess because of the fre
quent occurrence of artifacts on
Sudan IV staining.
Bacteremic colonization of any
foreign material exposed to blood
flow is a widely recognized problem
whose clinical importance has still
to be established. It is unlikely that
bacteria will be eliminated by any

Discussion
Table V. Effect of the Number of Human Umbilical Vein Segments on the Incidence of Infection

Since most specimens were re
trieved after thrombosis, we found
it difficult to assess their biostabili
ty. We also lacked a reliable control
group (prostheses implanted for an
equivalent length of time but with
out failure). It would be possible to
overcome this deficiency by examin
ing patent grafts from autopsies.
We believe that despite this lack of
a control group we have made some
observations that may have impor
tant future implications. One of
these is the high incidence of
thrombosis with HUV grafts. Ef
forts to develop an antithrombogenic flow surface seem reasonable.
However, treatment of the surface
by a mixture of heparin and alcohol
or heparin alone12 is questionable
since these techniques will deal only
with resistance to thrombosis and
will not necessarily resolve the com
plications related to bacteremic col
onization, aneurysmal formation,
lipid uptake and bioresorption.
Despite these complications, the
HUV graft is considered by
some1314 to be the best material for
below-knee revascularization when
autogenous saphenous vein is not
available. However, HUV is not the
perfect material and, as we have
demonstrated, grafts crossing the
knee survive only half as long as
those that do not. This may be
related to kinking of the graft at
the knee and the generally longer
length of the graft.
Lipid uptake and cholesterol de
position on the luminal surface of
the graft may be related to the
104
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No. of
segments
1
2
3

No. of
prostheses

Mean duration of
implantation, mo

% of grafts
excised for infection

61
13
6

12
3
3

20
46
50

Table VI. Effect of Dyslipidemia on the Luminal Deposition of Cholesterol Particles
Degree of
cholesterol
deposition
None
Minimal
Moderate
Large

No. of
prostheses
(n = 64)

Mean duration
of implantation,
mo

% of patients
suffering
dyslipidemia

35
21
5
3

11
10
18
8

30
9
0
0

Table VII. Relation Between the Clinical Declaration of infection and the Observation of Bacteria

Bacteria observed
No bacteria observed

Clinical
infection, no. (%)

No clinical
infection, no. (%)

17(24)
2 (3)

21 (30)
30 (43)

FIG. 3. Scanning electron micrograph of luminal surface of infected graft. Bacilli
can be seen on curoric matrix composed of fibrous tissue embedding erythrocytes
(original magnification X 1000).

J
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antibiotic therapy. Thus, the HUV
graft must be totally excised in
cases of an infected segment or
amputation.16
Imperfections of the luminal sur
face, such as folds, facilitate the
bacteremic colonization of the graft
wall. Moreover, these imperfections
could be implicated in the throm
botic process. The folds may result
from the HUV processing, which is
required to obtain a straight vessel.
Therefore, quality control tests
should be reinforced even if there is
already a high standard of selection
of the umbilical veins.
The high proportion of grafts

with bacteremic colonization but no
clinically observed infection is of
particular concern. It is difficult to
say whether these grafts are resis
tant to infection or whether the
infections were merely dormant,
awaiting the appropriate stimulus
to be activated. Any bacteria, how
ever transient, may have the poten
tial to infect HUV grafts.
These infections are often associ
ated with an inflammatory reaction
in the graft wall, which may lead to
thickening of the wall and therefore
contribute to mechanical graft fail
ure.
Bacteremic colonization is also

more likely when two or three um
bilical veins are anastomosed to
gether to construct a prosthesis of
sufficient length. One study17
showed that the addition of a su
ture line at the middle of a polytetrafluoroethylene prosthesis raised
the bacterial adherence by 50%.
Our clinical results with HUV agree
with this study. Suture lines be
tween anastomosed HUV grafts are
sometimes the site of aneurysmal
formation, thought to be related to
compliance mismatch between anas
tomosed HUV grafts.18 Measure
ment of graft compliance before
implantation, as a method of quality

•&

*
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%
-

■

jf * V,:

FIG. 4. Gram-positive cocci in tissue covering luminal surface
of clinically infected prosthesis implanted in 68-year-old
patient (Brenn and Brown stain, original magnification X
400).

FIG. 5. Media of prosthesis is infected throughout with
gram-positive bacilli. This prosthesis was implanted as femoropopliteal bypass for 2 months in 44-year-old man (Brenn
and Brown stain, original magnification X 400).

FIG. 6. Scanning electron micrographs of bacteremic colonization into folds of luminal surface of graft. (A) Folds of luminal
surface (original magnification X 20). (B) Cocci found in folds (original magnification X 2000).
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control, has been suggested for
vascular grafts of biologic origin.18
We consider that the anastomoses
between grafts are an important
factor in assessing the stability of
the HUV graft.
Interestingly, we have never ob
served such bacteremic colonization
in animal experiments. Bacteria en
countered in dogs do not show the
same resistance as bacteria encoun
tered in humans when antibiotics
are administered prophylactically.19
Therefore, new arterial prostheses
should be implanted with caution in
humans, no matter how successful
they have been in animals.

Conclusions
Increasing duration of HUV graft
implantation is associated with
greater degrees of encapsulation.
However, the surrounding inflam
matory reaction is less in explants
of longer duration. Clinical infec
tion tends to increase this degree of
inflammatory reaction. Bacterial
colonization in a substantial num
ber of clinically noninfected grafts
and the discovery of bacteria in
folds, often found in HUV grafts,
support the need for increased vigi
lance with respect to late complica
tions. We recommend complete ex

cision of clinically infected grafts.
Furthermore, in considering the ap
plication of HUV grafts, intergraft
anastomoses should be avoided if
possible because the frequency of
infection is higher, there is a poten
tial for aneurysm formation and the
duration of implantation is de
creased. The common finding of
delamination further supports the
continued surveillance of the bio
logic and structural changes in ex
cised HUV grafts.

We thank the operating room techni
cians and hospital attendants for col-

FIG. 7. Infection in folds of luminal surface. (A) Subintimal hemorrhagic sites (Weigert’s stain, original magnification X 400).
(B) Presence of gram-positive bacteria at these sites (Brenn and Brown stain, original magnification X 400).

FIG. 8. “Intermediate” inflammatory reaction between graft
wall and surrounding polyester mesh. This graft was removed
from 60-year-old woman because of infection (Weigert’s stain,
original magnification X 100).
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FIG. 9. Delamination of intima of graft implanted for 24 hours
(original magnification X 100).
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lecting and preparing the specimens.
The technical assistance of Marielle
Corriveau, Nicole Massicotte, Suzanne
Bourassa, Karen Horth and Richard
Couture was greatly appreciated. Meet
ings of the French and Quebec groups
were supported in part by the Echanges
France-Quebec.
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and diet program further burdens the
patient.
Since the conference’s purpose was
to involve all health-care disciplines, the
book is not directed at any specific
group, thus, there is inadequate detail
to interest most physicians. The surgi
cal concerns of epidemiology, diagnosis,
screening, operative technique, patholo
gy, adjuvant therapy and patient man
agement are too meagre for the Canadi
an surgeon’s needs.
J.E. Devitt, MD, CM, MSc, FRCS(Edin),
FRCSC
Ste. 310,
1081 C arlin g Ave.,
Ottawa, Ont.
K1Y4C2

HARDY’S TEXTBOOK OF SURGI
CAL MANAGEMENT. 2nd edition. Ed
ited by James D. Hardy. 1414 pp.
Illust. J.B. Lippincott Company, Phila
delphia, 1988. Price not stated. ISBN
0-397-50817-4.

This textbook is stated to be a highly
accessible book for “all standards of
surgery” . This is its major problem. A
book may be written for the undergrad
uate, the surgical resident or surgeon,
but not one book for all three. The
contributors all work in the United
States and have little interest in pre
senting work or giving references to
surgery elsewhere. The illustrations are
mostly line drawings. The good artistic
figures have generally been reproduced
from other surgical texts. As is so
common with multiauthored texts,
there is considerable difference in the
standard of the chapters.
The chapter on the breast might
have been written 25 years ago; it
contains many inaccuracies. In the sec
tion on screening, the HIP study is
described, but many important interna
tional studies, especially those from
Sweden, are not mentioned. The cur
rent “ gold standard” of treatment for
breast cancer is no longer modified
radical mastectomy, and surely there is
no place for it today. It is stated that
lymphatic drainage from cancers in the
medial half of the breast and the areolar
108
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region is mainly to the internal mamma
ry nodes. It has been established from
American and Italian studies that nodal
involvement is not related to the posi
tion of the tumour. Also, liver involve
ment is not the result of lymphatic
spread. Extensive axillary node dissec
tion is advocated, yet it has been estab
lished that control of disease in the
axillary nodes is as well accomplished
by radiotherapy as surgery. The term
roentgen is used in this book, yet it has
been supplanted first by the rad and
then the gray. Only scant reference is
made to receptor status, yet this has
assumed major importance and prog
nostic significance in patients with
breast cancer. All fibroadenomas should
not be enucleated; this leads to unnec
essary surgery in teenagers. Little refer
ence is made to the importance of
family history.
Other chapters, especially the first 16
on basic and support considerations, are
mostly well written and concise. Of the
remaining chapters, the ones on gyne
cologic surgery and on morbid obesity
are excellent.
In conclusion, I think better texts
than this one are available, for the
student, the resident or the surgeon.
John A. McCredie, MB, MCh, FRCS,
FRCS(Edin), FRCSC, FACS
Department o f Surgery,
Victoria Hospital,
London, Ont.
N 6 A 4C5

OBSTETRIC ANESTHESIA: THE
COMPLICATED PATIENT. Edited by
Francis M. James, III, A. Scott Whee
ler and David M. Dewan. 577 pp.
Illust. F.A. Davis Company, Philadel
phia, 1988. $79.00 (US). ISBN
0-8036-4914-2.

mortality are reviewed. A section on
anesthesia for the uncomplicated pa
tient is included, but the emphasis is on
complications of the anesthesia.
The section entitled “Maternal prob
lems by system” covers all the major
systems and is the core of the text. The
chapter on neurologic disease is well
done with a good discussion on epilepsy
during pregnancy. One excellent chap
ter is that on hematologic disease in
which a discussion on coagulation dis
orders is particularly complete. The
section on fetal problems includes a
unique chapter on fetal surgery along
with the topics of preterm delivery and
fetal distress. The last section of the
text is reserved for what the editors
consider special problems, including di
abetes, pregnancy-induced hypertension
and non-obstetric surgery, together
with more unusual chapters such as
one on the febrile parturient, the obese
parturient, the traumatized obstetric pa
tient and substance abuse.
The editors have done a commenda
ble job in bringing together experts in
the field, including Canadian research
ers Biehl and Palahniuk in Winnipeg,
McMorland in Vancouver and Writer in
Halifax. The chapters are well refer
enced and, for the most part, very up to
date. Controversial areas are well ad
dressed and the authors usually give
practical direction to the reader. Most
topics or treatment protocols are sum
marized in tables or outlines, and many
graphs have been reproduced from the
literature to illustrate the results of
investigation. The index is extensive
and includes references to tables and
figures.
In summary, the text is a welcome
addition to my bookshelf. It serves as
an excellent bridge between obstetrics
and internal medicine and yet maintains
the perspective of the anesthetist.
Robert D. Elliott, MD, FRCPC

This text, as its title suggests, focuses
on the administration of anesthesia dur
ing labour to women with problem
pregnancies. In the first section, aspects
of maternal and fetal physiology are
covered and a good discussion of fetal
assessment and monitoring is provided.
There is also an excellent chapter in
which maternal and fetal morbidity and

Coordinator,
Obstetrical Anesthesia,
Ottawa General Hospital.
501 Smyth Rd.,
Ottawa, Ont.
K1H 8L6
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Identification of Clinically Significant
Skeletal Muscle Necrosis by Single Photon
Emission Computed Tomography
I. Forrest, MD, FRCSC;* G. Hayes, MD, FRCSC;* A. Smith;f T-C.K. Yip, MD, FRCPC;t
Paul M. Walker, MD, PhD, FRCSC*
Ischemia-reperfusion damage to skeletal muscle may cause serious local as well as
systemic complications, its impact predominantly related to the quantity of ischemic
muscle in the lower extremity. To date, there has been no noninvasive method of
estimating that quantity. The authors used single photon emission computed
tomography (SPECT) to quantify the volume of muscle that takes up technetium-99
pyrophosphate above a baseline threshold. Compared with the standard technique of
staining slices of the muscle with nitroblue tetrazolium they found a close
correlation using SPECT (r = 0.88, p < 0.01, n = 19) in the canine model. In
humans, this clinically applicable noninvasive technique may allow the surgeon to
document accurately the extent of muscle necrosis in the lower extremity, to
anticipate the impact of an ischemia-reperfusion injury and evaluate methods of
reducing the extent of post-ischemic skeletal muscle necrosis.

►
►

>

Les dommages ischemiques de reperfusion des muscles squelettiques peuvent causer
des complications locales et generates graves; leur importance est d’abord reliee a la
quantite de muscle ischemique dans les membres inferieurs. Jusqu’a ce jour on ne
connaissait aucune methode non sanglante pour apprecier cette quantite. Les
auteurs ont utilise la tomographie a emission photonique simple (TEPS) pour
quantifier le volume musculaire qui fixe le pyrophosphate de technetium-99 au
dessus d’un seuil de base. Comparativement a la technique courante qui consiste a
colorer des coupes de muscle a l’aide de nitrobleu de tetrazolium, ils ont trouve,
chez le chien, une etroite correlation avec la TEPS (r = 0.88, p < 0.01, n = 19).
L’application clinique de cette technique non sanglante chez l’humain peut
permettre au chirurgien d’etablir precisement l’etendue d’une necrose musculaire
dans les membres inferieurs, d’anticiper l’effet des lesions ischemiques de reperfu
sion et d’evaluer les methodes visant a reduire la necrose post-ischemique des
muscles squelettiques.

i
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uantification of necrotic muscle
in the lower extremity is a
challenging clinical problem. Isch
emia over a prolonged period,
caused by acute arterial thrombosis
or embolism, may be relieved surgi
cally, but the combination of meta
bolic events during ischemia and
those resulting from reperfusion
leads to cellular damage.1 We have
demonstrated previously2 that there
is a gradation in the extent of
ischemic damage related to the time
of absent circulation. In contrast to
myocardial or cerebral ischemic
damage, relatively large quantities
of skeletal muscle necrosis can be
tolerated without permanent disabil
ity. Clinical techniques for estimat
ing the extent of necrosis have been
limited to visual examination during
fasciotomy (to reduce compressive
muscle death) or apparent alter
ations in muscle
contractions
(which may be inaccurate due to
concomitant nerve injury). We have
described a method for accurately
evaluating skeletal muscle necrosis
in the canine gracilis m uscle model
using a combination o f nitroblue
tetrazolium staining and computed
planimetry.3 The results compare
favourably with the technetium-99
pyrophosphate (PYP) uptake in this
animal model using calibration of
the density of the isotope uptake
per gram of tissue, assessed after
muscle removal.4 Both techniques

Q
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are invasive and not applicable clini
cally. A noninvasive technique for
evaluating the quantity of tissue
containing radioactivity above a
threshold level has been developed,
using single photon emission com
puted tomography (SPECT). In this
report we compare the ability of
SPECT to quantify muscle necrosis
in the canine model with standard
invasive techniques.

sides of the slice was multiplied by
the weight to determine the volume
(ml) of necrosis per slice.6
Transaxial slices were obtained
by filtered back projection using a
Hanning filter (a mathematical
function used to reduce background
variation) at 1 pixel thickness. A
pixel is the smallest division of the

field of view of the gamma camera
recognized by the computer (0.44
cm2). The edge of each slice was
determined using a threshold meth
od.7 The pixel counts from all slices
were then summed. The volume of
necrosis with PYP activity (the vol
ume of necrotic muscle) was com
puted by multiplying the summed
19
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In our study we used the bilateral
canine gracilis muscle model de
scribed previously.5 Both muscles
were isolated on a single vascular
pedicle by dividing all collateral ves
sels, including the minor pedicle,
the nerve and both tendinous at
tachments, with resuturing to pre
serve resting muscle tension. Re
versible periods of ischemia were
produced by applying microvascular
clips to the vascular pedicle for 4
hours. Normal reperfusion was in
duced by removing the clips, and
the patency of the pedicle was as
sured by Doppler ultrasound. The
muscles were harvested for evalua
tion 48 hours later, 2 hours after
injection of technetium-99 PYP
(250 MBq). Both gracilis muscles
were harvested and scanned using a
large field of view gamma camera.
Single photon emission computed
tomography was performed with a
64 X 64 matrix, low energy, all
purpose collimator, using an ellipti
cal orbit with a total acquisition
time of approximately 30 minutes.
When imaging was complete, each
muscle was cut into six slices,
weighed and incubated with nitroblue tetrazolium. The volume of ne
crosis in each slice was established
using computed planimetry. The
mean of the dead area divided by
the mean of the total area on both

FIG. 1. Technetium-99 pyrophosphate scan of gracilis muscle in sagittal section
(top) and coronal axis (bottom).

i

MUSCLE NECROSIS AND COMPUTED TOMOGRAPHY

included, the correlation coefficient
was r = 0.93 (p < 0.001).

number of pixels by the voxel size.
A voxel is a measure of the volume
of the product of one pixel and slice
thickness (0.29 cm3). (The thresh
old and ability of this method to
quantify the volume of necrosis in
syringes containing a solution of
technetium-99 PYP had already
been established.8)
Statistical significance was deter
mined by linear regression analysis.

Discussion
The prognosis following pro
longed ischemia-reperfusion in the
lower extremity depends mainly on
the effects of muscle tissue and, to
a lesser extent, the nerve.9 Inade
quate revascularization is seldom
the cause of major morbidity or
mortality. Systemic consequences of
muscle ischemia are the commonest
cause of death. The washout of
lactate, hydrogen and potassium
ions, myoglobin and other toxic
materials may lead to hypotension,
cardiac or renal failure.10 Morbidity
following a severe ischemia-reperfu
sion injury to the lower extremity
ranges from the need for urgent
amputation (usually at a higher
level than for chronic conditions) to
motor dysfunction resulting in
long-term disability and the pa
tient’s inability to return to previ-

Results
Nineteen muscles were studied.
Sample scans in the coronal plane
and in sagittal section are shown in
Fig. 1, and transaxial projections
are shown in Fig. 2. The volume of
necrosis as measured by tetrazolium
staining techniques and by SPECT
for all points is shown in Fig. 3.
Over a range of necrosis from less
than 1 ml to more than 175 ml, the
correlation was r = 0.88 (p <
0.001). When only volumes of ne
crosis greater than 20 ml were
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ous occupations.11 Limb dysfunc
tion may be the result of muscle or
nerve damage or both. Therefore,
determining the extent of damage
to skeletal muscle by a noninvasive
method is pivotal in assessing the
impact of ischemia-reperfusion.
Quantification of post-ischemic
skeletal muscle necrosis in the
lower extremity has not been avail
able to date. Our previous work12 in
quantifying skeletal muscle necrosis
in the canine gracilis muscle model
demonstrated the usefulness of
technetium-99 PYP. We used
the suggested 48- to 72-hour win
dow for our evaluation of necrosis.
This is when intracellular accu
mulation of technetium (a calcium
ion follower) best reflects ongoing
necrosis.12 The addition of SPECT
for quantifying radioisotope accu
mulation may permit reliable trans
fer to the clinical situation of a
technique developed in the laborato
ry. Comparison of the gold standard
of tetrazolium staining and SPECT
demonstrated a close relationship
between these two measurements of
the volume of necrotic tissue within
a gracilis muscle. We concluded
that only when the amount of ne
crosis is small is there a substantial
discrepancy between the two mea
surements.
The clinical usefulness of this
noninvasive measurement remains
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FIG. 2. Transaxial projection of both gracilis muscles, with threshold used for
calculation of volume of necrosis.

FIG. 3. Graph showing relation be
tween volume of necrosis as measured
by tetrazolium staining and uptake of
technetium-99 pyrophosphate (r =
0.88, p < 0.01, n = 19).
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to be clearly defined. The quantifi
cation of ischemic muscle in the
lower extremity may allow us to
predict the outcome of the injury
and determine earlier the need for
amputation or debridement. This
technique may also be useful pro
spectively for choosing therapeutic
interventions aimed at reducing is
chemia-reperfusion injury, as has
been demonstrated in animal experi
ments.13
We believe that technetium-99
PYP accurately identifies necrotic
skeletal muscle when measured 48
to 72 hours after an ischemia-reper
fusion injury. Single photon emis
sion computed tomography is a
clinically useful method for quanti
fying the accumulation of radioiso
tope, as a direct measurement of
the volume of ischemic muscle pres
ent in the lower extremity.
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cost effective
prophylactic
alternative
cefotaxime
sodium

in contaminated
or potentially
contaminated
gastro-intestinal
surgery
Claforan

.. was superior

in preventing infectious
morbidity and side effects
and reduced hospital
drug costs compared
directly with multidose
regimens of cefazolin
or cefoxitin (p value not
statistically significant)
Dr. R.N. Jones
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For prescribing information see reverse

ram
Action
In vitro studies indicate that the bacterial action of CLAFORAN (cefotaxime sodium)
a semi-synthetic cephalosporin antibiotic, results from inhibition of cell wall
synthesis.
Indications and Clinical Uses
Treatm ent: CLAFORAN (cefotaxime sodium) may be indicated for the treatment
of infections caused by susceptible strains of the designated micro-organisms
in the diseases listed below.
Lower respiratory tra ct in fe c tio n s: pneumonia and lung abscess caused by
Streptococcus pneumoniae (formerly Diplococcus pneumoniae), other streptococci
(excluding enterocci, eg. S. faecalis), Straphylococcus aureus (penicillinase and
non-penicillinase producing), Escherichia coli, Hemophilus influenzae, (including
ampicillin resistant strains) and unspecified Klebsiella species.
U rinary tract in fe c tio n s : caused by Escherichia coli, unspecified Klebsiella
species (including K pneumoniae), Proteus mirabilis, indole positive Proteus, Serratia marcescens and Staphylococcus epidermidis. Also, uncomplicated gonor
rhea caused by N. gonorrhoeae including penicillin resistant strains
B a c te re m ia /S e p tice m ia : caused by Escherichia coli, unspecified Klebsiella
strains and Serratia marcescens.
Skin in fe c tio n s: caused by Staphylococcus aureus (penicillinase and non
penicillinase producing, S. epidermidis, Group A streptococci, Escherichia coli,
Proteus mirabilis and indole positive Proteus.
Intra-abdominal infections: caused by Escherichia coli, and unspecified Kleb
siella species.
Gynecological infe c tio n s: including pelvic inflammatory disease, endometritis
and pelvic cellulitis caused by E. coli, Group A streptococci and Staphylococcus
epidermidis-, anaerobic bacteria including unspecified Peptococcus and Peptostreptococcus strains and some strains of Bacteroides fragilis. In several cases, although
clinical cures were achieved, bacteriological follow-up was not available.
Clinical experience with CLAFORAN in anaerobic infections is limited. CLAFORAN
has been used with some success in wound and intra-abdominal infections against
some strains of unidentified Bacteroides and anaerobic cocci.
CLAFORAN has been shown to be active against some strains of Pseudomonas.
In the treatment of infections encountered in immunosuppressed and granulo
cytopenic patients, results of therapy with CLAFORAN have not been impressive.
CLAFORAN should not be considered in the treatment of enterococcal infections,
i.e. Streptococcus faecalis
Specimens for bacteriologic culture should be obtained prior to therapy in order
to isolate and identify the causative organisms and to determine their suscep
tibilities to CLAFORAN. Therapy may be instituted before results of susceptibility
studies are known; antibiotic treatment should be re evaluated once these results
become available.
Prophylactic U s e ; The administration of CLAFORAN perioperatively (preoperative
ly, intraoperatively and postoperatively) may reduce the incidence of certain infec
tions in patients undergoing elective surgical procedures (e.g. abdominal or vaginal
hysterectomy, gastrointestinal and genitourinary tract surgery) that may be classified
as contaminated or potentially contaminated.
In patients undergoing caesarian section who are considered to be at increased
risk of infection, intraoperative (after clamping the umbilical cord) and postoperative
use of CLAFORAN may also reduce the incidence of certain postoperative infections.
Effective use for elective surgery depends on the time of administration (see Dosage
and Administration).
For patients undergoing gastrointestinal surgery, preoperative bowel preparation
by mechanical cleansing as well as with a non absorbable antibiotic (e.g. neomycin)
is recommended.
If there are signs of infection, specimens for culture should be obtained for iden
tification of the causative organism so that appropriate therapy may be instituted.
Contraindications
CLAFORAN is contraindicated in patients who have shown hypersensitivity to
cefotaxime sodium, the cephalosporin or the penicillin groups of antibiotics.
Warnings
Before therapy with CLAFORAN is instituted, it must be carefully determined whether
the patient has had previous hypersensitivity reactions to cefotaxime,
cephalosporins, penicillins or other drugs CLAFORAN should be given with caution
to patients with Type 1 hypersensitivity reactions to penicillin. Antibiotics, including
CLAFORAN should be administered with caution to any patient who has
demonstrated some form of allergy, particularly to drugs. If an allergic reaction
to CLAFORAN occurs, the drug should be discontinued and the patient treated
with the usual agents (e.g. epinephrine, antihistamine, pressor-amines or
corticosteroids).
Pseudomembranous colitis has been reported with the use of cephalosporins
(and other broad spectrum antibiotics); therefore, it is important to consider its
diagnosis in patients who develop diarrhea during the administration of CLAFORAN.
This colitis can range from mild to life-threatening in severity.
Treatment with broad spectrum antibiotics, such as CLAFORAN, alters the nor
mal flora of the colon and may permit overgrowth of Clostridium difficile or other
Clostridia. It has been established that a toxin produced by Clostridium difficile
is one primary cause of antibiotic-associated colitis.
Mild cases of colitis may respond to discontinuation of CLAFORAN and replace
ment with a suitable specific antibiotic. Moderate to severe cases should be manag
ed with fluid, electrolyte and protein supplementation as indicated. When the colitis
is not relieved by discontinuance of CLAFORAN administration or when it is severe,
an antibiotic specifically effective in antibiotic-associated pseudomembranous colitis
(e.g. vancomycin) or other suitable therapy may be indicated. Other possible causes
of colitis should also be considered (see Adverse Reactions).
Precautions
CLAFORAN (cefotaxime sodium) should be prescribed with caution in individuals
with a history of lower gastrointestinal disease particularly colitis.
The safety of CLAFORAN in pregnancy has not been established. Consequently,
use of the drug in pregnant women requires that the likely benefit from the drug
be weighed against the possible risk to the mother and fetus.
Use of CLAFORAN in women of child-bearing potential requires that the anticipated
benefits be weighed against the possible risks.
Cefotaxime is excreted in human milk in low concentrations. Caution should be
exercised when the drug is administered to nursing mothers.
Prolonged use of CLAFORAN may result in the overgrowth of nonsusceptible
organisms. Constant evaluation of the patient’s condition is essential. If super

infection occurs, therapy should be discontinued and appropriate measures taken.
Although CLAFORAN rarely produces alterations in kidney function, evaluation
of renal status is recommended, especially in severely ill patients receiving high
doses.
Patients with markedly impaired renal function should be placed on the special
dosage schedule recommended under Dosage and Administration, because nor
mal dosage in these individuals is likely to produce excessive and prolonged serum
antibiotic concentrations.
Positive direct Coomb’s test is known to develop in individuals during treatment
with the cephalosporin group of antibiotics, including cefotaxime sodium.
In laboratory tests a false positive reaction to glucose may occur with reducing
substances but not with the use of specific glucose oxidase methods.
Adverse Reactions
The most frequent adverse reactions with their frequency of occurrence are
Hypersensitivity (1.8%): Rash, pruritus, fever. Local (5%): Injection site inflam
mation with intravenous administration. Pain, induration and tenderness after in
tramuscular injection. Gastrointestinal (1.7%): Colitis, diarrhea, nausea and
vomiting. Symptoms of pseudomembranous colitis can appear during or after
CLAFORAN treatment. H em ic and Lymphatic System ( < 1%): Mild, reversi
ble leukopenia, granulocytopenia and thrombocytopenia have been reported. Some
patients developed positive direct Coomb’s test during treatment with CLAFORAN.
Genitourinary System ( < 1%): Moniliasis, vaginitis. Liver ( < 1%): Transient
elevations in SGOT, SGFT, serum LDH and serum alkaline phosphatase levels
have been reported. Kidney ( < 1%): Increased serum creatinine and BUN have
occasionally been observed. Central Nervous System (0.2%): Headache.
Symptoms and Treatment of Overdosage
Since no case of overdosage has been reported to date with CLAFORAN, no
specific information on symptoms or treatment is available. Treatment of over
dosage should be symptomatic.
Dosage and Administration
CLAFORAN (cefotaxime sodium) may be administered intramuscularly or in
travenously after reconstitution (see Table with recommended mode of reconstitution
according to route of administration).

large muscle such as the upper outer quadrant of the buttock (i.e. gluteus maximus); aspiration is necessary to avoid inadvertent injection into a blood vessel.
Intravenous: The intravenous route is preferable for patients with bacteremia,
bacterial septicemia, or other severe or life-threatening infections, or for patients
who may be poor risks because of lowered resistance resulting from such
debilitating conditions as malnutrition, trauma, surgery, diabetes, heart failure,
or malignancy, particularly if shock is present or impending.
For bolus administration a solution containing 1 or 2 g of CLAFORAN can be
injected over a period of 3 to 5 minutes. Using an infusion system, it may also
be given over a longer period of time through the tubing system by which the
patient may be receiving other intravenous solutions Butterfly* or scalp vein type
needles are preferred for this type of infusion. However, during infusion of the
solution containing CLAFORAN, it is advisable to discontinue temporarily the ad
ministration of other solutions at the same site.
Reg'd TM of Abbott Laboratories.
Reconstitution
For Intramuscular U se: CLAFORAN should be reconstituted with Sterile Water
for Injection or Bacteriostatic Water for Injection in accordance with the volumes
recommended in the following table.
Reconstitution Table

Intramuscular

Guidelines for Dosage of CLAFORAN (cefotaxime sodium)
Daily Dose
(9)

Approximate
Available
Vol. (mL)

Approx. Average
Concentration
(mg/mL)

2
3
5

2.2
6.0

230
300
330

500 mg vial
1 g vial
2 g vial

3.4

•shake to dissolve.
For direct intravenous injection (bolus) and / or continuous intravenous
in fu s io n : 500 mg, 1 and 2 g vials should be reconstituted with at least 10 mL
of Sterile Water for Injection. Reconstituted solution may be further diluted with
50 to 1000 mL of the fluids recommended for IV infusion.
Reconstitution Table

Dosage
Adults
The dosage of CLAFORAN should be determined by susceptibility of the causative
organisms, severity of the infection and condition of the patient.

Volume to be
Added to
Vial (mL)*

Intravenous
500 mg vial 10
1 g vial
2 g vial

Volume to be
Added to
Vial (mL)*

Approximate
Available
Vol. (mL)

Approx. Average
Concentration
(mg/mL)

10.2
10
10

50
10.4
11.0

180

95

•shake to dissolve.
Solutions for IV In fu s io n : CLAFORAN is compatible with the following infu
sion
fluids:
1
1 g IM (single dose)
Uncomplicated
- Sterile Water for Injection
Gonorrhea
- 0.9% NaCI injection
Uncomplicated
2
1 g every 12 hours
- 5% dextrose injection
IM or IV
infections
0.9% NaCI and 5% dextrose injection
Moderately
3-6
1-2 g every
- 0.45% NaCI and 5% dextrose injection
8 hours IM or IV
severe to severe
0.2%
NaCI and 5% dextrose injection
infections
- Sodium Lactate injection
2g every
Very severe
6-8
- 5% dextrose and 0.15% KCI injection
6-8 hours IV
infections (e.g.
- Plasma-Lyte 56 Electrolyte Solution in 5% dextrose injection
septicemia)
- Ringer’s injection
Life-threatening
2g every
up to 12
- Lactated Ringer’s solution
infections
4 hours IV
- Lactated Ringer’s with 5% dextrose injection
CLAFORAN is also compatible with lignocaine 1%.
To prevent postoperative infection in contaminated or potentially contaminated A solution of 1 g of CLAFORAN in 14 mL of Sterile Water for Injection is isotonic.
Stability of Solution
surgery, recommended doses are as follows.
S tora ge: Solutions of CLAFORAN range from light yellow to amber, depending
(a) 1g IM or IV administered Vz to 1’/2 hours prior to the initial surgical incision
to ensure that adequate antibiotic levels are present in the serum and tissues on concentration and the diluent used. The solutions tend to darken depending
on storage conditions and should be protected from elevated temperatures and
at the start of surgery
excessive light.
(b) 1 g IM or IV administered 1V2 to 2 hours following the first dose; for lengthy
**Reg’d TM of Baxter-Travenol Laboratories.
operative procedures, additional intraoperative doses may be administered, if
CLAFORAN reconstituted in the original vial as described under Reconstitution
necessary, at appropriate intervals (IV 2 to 2 hours) during surgery
maintains satisfactory potency for 24 hours at room temperature (25°C) and for
(c) 1 g IM or IV administered within 2 hours following completion of surgery
48 hours under refrigeration (0-5°C). Only freshly prepared reconstituted solu
The total cumulative prophylactic dose should not exceed 6 g in a 12 hour period. tions may be further diluted with 50 to 1000 mL of the recommended infusion
fluids in Viaflex*’ intravenous bags. Such solutions maintain satisfactory poten
Caesarian Section Patients
The first dose of 1g is administered IV as soon as the umbilical cord is clamped. cy for 24 hours at room temperature (25°C) and for 72 hours under refrigeration
The second and third doses should be given as 1 g IM or IV at 6 and 12 hours (0-5°C). Any unused solutions should be discarded.
CLAFORAN reconstituted with 1% lignocaine maintains satisfactory potency for
after the first dose.
up to 24 hours at room temperature and 48 hours under refrigeration (reference
Neonates, Infants, and Children
to
lignocaine restrictions is advisable).
The following dosage schedule is recommended:
CLAFORAN solutions exhibit maximum stability in the pH 5-7 range.
Neonates:
0-1 week of age
50 mg / kg IV q 12 h
Special Instru ctions: Parenteral drug products should be inspected visually
1-4 weeks of age
50 mg / kg IV q 8 h
for particulate matter and discoloration prior to administration. Solutions of
Infants and children (1 month to 12 years): For body weights less than 50 kg, CLAFORAN range from light yellow to amber, depending on concentration and
the recommended daily dose is 50 to 100 mg / kg IM or IV of body weight divid diluent used. The dry powder as well as solutions tend to darken, depending
ed into 4 to 6 equal doses, or up to 180 m g/kg/day for severe infections.
on storage conditions.
For body weights 50 kg or more, the usual adult dosage should be used.
Incom patibilities: Solutions of CLAFORAN must not be admixed with
aminoglycoside solutions. If CLAFORAN and aminoglycosides are to be ad
The maximum daily dosage should not exceed 12 grams.
Administration of CLAFORAN should be continued for a minimum of 48 to 72 ministered to the same patient, they must be administered separately and not
hours after the patient defervesces or after evidence of bacterial eradication has as a mixed injection.
been obtained; a minimum of 10 days of treatment is recommended for infec Solutions of CLAFORAN should not be prepared with diluents having a pH above
tions caused by Group A beta-hemolytic streptococci in order to guard against 75 such as Sodium Bicarbonate Injection.
the risk of rheumatic fever or glomerulonephritis; frequent bacteriologic and clinical Availability
appraisal is necessary during therapy of chronic urinary tract infections and may Claforan (cefotaxime sodium) is supplied as a sterile, white to pale yellow powder,
be required for several months after therapy has been completed; persistent in in vials containing 500 mg, 1.0 and 2.0 g of cefotaxime sodium (expressed as
fections may require prolonged treatment. Doses less than those recommended acid on a dry basis).
should not be employed.
S to ra g e : CLAFORAN in the dry state should be stored at room temperature,
Dosage for Patients with Impaired Renal Function
protected from light and heat.
In patients with estimated creatinine clearance of less than 20 m L /m in / 1.73m2 Product monograph available on request
the dose of CLAFORAN should be halved (see Precautions).
Reference
If serum creatinine values alone are available, the following formula (based on
Jones R.N. et a l.: Antibiotic Prophylaxis of 1036 Patients Undergoing Elective
sex, weight, and age of the patient) may be used to convert these values into
Surgical Procedures. The American Journal of Surgery, 1987; 153: 341-346.
creatinine clearance.
Males: Weight (kg) x (140 - age) Females: 0.85 x above value
Type of Infection

Frequency and Route

72 x serum creatinine
Administration
Intram uscular: CLAFORAN should be injected well within the body of a relatively
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Extra-Anatomic Bypass Grafting: a Rational
Approach
K.A Harris, MD, FRCSC; V. Niesobska; S.E. Carroll, MD, FRCSC; G. De Rose, MD, FRCSC;
W.G. Jamieson, MD, FRCSC; G.E. Meads, MD, FRCSC; J.P. Sweeney, MD, FRCSC
To determine predictors of long-term patency in extra-anatomic bypass grafting, the
authors studied retrospectively the charts of 134 patients who underwent bypass grafting
(axillofemoral in 17, axillobifemoral in 32 and femorofemoral in 85). Of the study group,
64% were men; the mean age was 65 ± 12 years (±SEM). The indications for grafting
were limb salvage (102), claudication (27) and replacement of septic grafts (5), and for
using the extra-anatomic route included high risk (83), sepsis (8) and unilateral disease
(34). Operative mortality was 6% and the early graft occlusion rate 7.4%. The late death
rate was 44%. At 3 years, the life-table patency rates for the various procedures were
axillofemoral 52.5%, axillobifemoral 67.7% and crossfemoral 86.9%. Smoking
significantly (p < 0.05) decreased the patency rate, but diabetes did not. However,
amputation was more frequent in diabetics. Indications for operation did not alter patency
rates, but did affect operative mortality. The authors conclude that extra-anatomic bypass
grafting is highly successful, but not as successful as anatomic bypass. When
appropriate, the axillobifemoral graft is preferred to the axillounifemoral graft because of
its increased patency. Crossfemoral grafts must be carefully monitored to ensure that no
donor limb stenosis occurs and this procedure should not be attempted unless the disease
is truly unilateral.
Les auteurs ont etudie de fafon retrospective les dossiers de 134 patients qui avaient subi
des interventions de derivation (17 axillofemorales, 32 axillobifemorales et 85 femorofemorales) afin de determiner quels sont les facteurs previsionnnelles de permeabilite a
long terme dans les cas de pontage extra-anatomique. Du groupe etudie, 64% etaient des
hommes; l’age moyen etait de 65 ± 12 annees. La sauvegarde d’un membre (102), une
claudication (27) ou le remplacement d’un greffon infectes (5) constituaient les causes de
pontage. Les raisons invoquees pour utiliser une voie extra-anatomique comprenaient un
risque eleve (83), une sepsie (8) et une atteinte unilaterale (34). La mortalite operatoire
fut de 6% et le taux d’occlusion precoce du greffon, de 7.4%. La mortalite tardive a ete de
44%. Apres 3 ans, le taux actuarielle de permeabilite etait de 52.5% pour les pontages
axillofemorales, de 67.7% pour les axillobifemorales et de 86.9% pour les femorofemorales. L’usage du tabac a reduit de fa?on significative (p < 0.05) le taux de permeabilite, mais
pas le diabete. Neanmoins, l’amputation a ete plus frequente chez les diabetiques. Les
indications operatoires n ’ont pas influence le taux de permeabilite mais elles ont affecte la
mortalite operatoire. Les auteurs concluent que les pontages extra-anatomiques ont un
haut taux de succes, mais pas autant que les derivations anatomiques. Quand c’est
possible, le pontage axillobifemoral doit etre prefere a l’axillobifemoral, car il presente un
meilleur taux de permeabilite. Les pontages femorofemoraux doivent etre surveilles
etroitement afin de s’assurer qu’il n’y a pas de stenose de la partie donneuse; cette
intervention ne devrait pas etre pratiquee a moins que l’atteinte soit vraiment unilaterale.
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raditionally, vascular reconstruc
tion has followed the course of
the native arterial tree. Sometimes,
because of medical risk, old age or a
locally hostile environment, it may be
beneficial to avoid entering the major
body cavities. The first axillofemoral
extra-anatomic bypass was described
in 1962 by Blaisell and Hall.1 Since
then, the procedure has been modified
to incorporate a crossover femoral
limb to revascularize both ischemic
lower extremities.2 The reported
death and patency rates using these
bypasses have varied,3'7 possibly
owing to patient selection, indications
for operation and operative technique.
Another procedure used to avoid
direct aortic surgery is crossover fem
oral grafting.8 This procedure may be
used in young patients with truly
unilateral disease, the elderly with
critical ischemia secondary to iliac
artery occlusion, and in patients with
failure of one limb of an aortobifemoral bypass graft.911 Acceptance of this
procedure for these indications has
been again sporadic. The axillofemor
al, axillobifemoral and crossover fem
oral bypasses are most commonly
used; however, indications, complica
tion rates and expected patency rates
remain controversial. In an effort to
define the role of these procedures
and to assess our centre’s success
rate, we reviewed retrospectively all
axillofemoral, axillobifemoral and
crossover femoral grafts that were
carried out at the vascular units of
St. Joseph’s Hospital and Victoria
Hospital in London, Ont., over the
past 10 years.

T

Patients and Methods
A medical student reviewed the
CJS, VOL. 32, NO. 2, MARCH 1989
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charts of all 134 patients who under
went any of the designated opera
tions. Follow-up information was ob
tained from the surgeon’s office
charts or by telephone from the pa
tient or family doctor.
The findings were subjected to sta
tistical analysis by the life-table meth
od or x 2test as required.

Findings
Of 134 patients, an axillofemoral
graft was placed in 17, axillobifemoral
in 32 and a crossover femoral graft in
85. The mean (±SD) age of the
patients was 65 ± 12.6 years (range
from 39 to 93 years); 64% of the
patients were men.
The indications for bypass grafting
were critical limb ischemia in 102
(76%), disabling claudication in 27
(20%) and reconstruction following
graft excision for infection in 5 (4%).
Fifty-six (42%) patients had under
gone bypass grafting previously. Indi
cations for using the extra-anatomic
route were intra-abdominal or graft
sepsis in 8 (6%) and high medical risk
in 83 (64%). Occasionally, factors
associated with previous reconstruc
tions (in 42% of patients) are indica
tions for extra-anatomic bypass. In
the crossover femoral graft group, 34
patients had donor iliac arteries that
were considered to be normal, though
no grafts were taken from a donor
limb with a flow-limiting stenosis.

In 95% of cases the graft material
was polytetrafluoroethylene, and 98%
of the grafting procedures were per
formed under general anesthesia. No
late graft degeneration or aneurysm
formation was documented.
To permit adequate outflow for the
graft and maintain patency, profundaplasty was used liberally, particularly
when there was stenosis of the origin
of the deep femoral artery. There was
no concomitant femoropopliteal by
pass grafting which may indicate the
presence of well-developed collateral
circulation.
The operative death rate (within 30
days of operation) was 6%; eight
patients died of cardiac, pulmonary or
central nervous system causes (Table
I). The rate was increased when the
indication for operation was limb sal
vage. The operative occlusion rate
was 9% (Table I) and was not affected
by indications for bypass surgery, risk
factors present before surgery or the
occurrence of other complications.
At the time of writing, 59 (44%) of
the patients had died. The patency
rate was 66% (88 patients); this group
comprised 59 patients who were alive
with patent grafts and 29 patients in
whom the graft was patent when they
died. None of the patients in this
group required thrombectomy. The
secondary patency rate was 86% for
all grafts. Twenty-four patients un
derwent thrombectomy to maintain
patency. When results were analysed
by the life-table method, the standard

Table 1. O p e ra tive C o m p lic a tio n s

C om plication

Xfem,
no. (% )
(n = 85)

O c c lu s iv e
P u lm o n a ry
C e n tra l n e rv o u s s y s te m
C a rd ia c
R e n al
S e p tic

4 (5 )
5 (6 )

D ied

2 (2 )

T o ta ls

1 (1)
2 (2 )
1 (1)
1 0)

16

Axfem,
no. (% )
(n = 17)
3 (1 8 )
0
0
0
0

Axbifem ,
no. (% )
(n = 32)
3 (9 )
3 (9 )

1 (6 )

1 (1 )
6 (1 9 )
0
0

1 (6 )

6 (1 6 )

5

19

Totals,
no. (% )
(n = 134)
1 0 (7 )
8 (6 )
2 (1 )
8 (6 )
1 (1 )
2 (1 )
9 (7 )
40

X fe m = c ro s s fe m o ra l g ra fts , A x fe m = a x illo fe m o ra l g ra fts , A x b ife m = a x illo b ife m o ra l g ra fts.
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error was found to be too large after 3
years for meaningful analysis, so fol
low-up results were not included after
that time. The 3-year primary patency
rates were as follows: crossover femo
ral 86.9% ± 4.1% (Fig. 1), axillobifem
oral 67.7% ± 9.8% and axillofemoral
52.5% ± 15.3% (Fig. 2). Long-term
graft patency was not affected by the
indications for operation, presence of
diabetes, the size of the graft or the
status of run-off vessels as determined
angiographically. In smokers (96), the
patency rate was significantly (p <
0.05) reduced in comparison with
nonsmokers (38). Of the 24 patients
who required thrombectomy to main
tain graft patency 20 were smokers.
The limb salvage rate (defined as
patients not requiring a transmetatar
sal or higher amputation) was 82%.
Factors affecting salvage rate (p <
0.05) are indications for operation and
the presence of diabetes. Limb salvage
was associated with, but not absolute
ly dependent upon, graft patency.
None of the grafts that were inserted
to reconstruct septic grafts became
occluded. In the crossfemoral group
there was no improvement in patency
for patients who had truly unilateral
disease (occluded single limb of aortobifemoral graft or otherwise).

Discussion
Extra-anatomic bypass grafting is
becoming more widely accepted. Our
absolute indications include the need
for reconstruction following excision
of an infected graft and when peritoni
tis precludes anatomic reconstruc
tion. The more controversial indica
tions include high medical risk, a
desire to avoid an intracavitary proce
dure and strictly unilateral disease.
The operative death rate in our series
of 6% compares favourably with more
major reconstructions. This rate may
reflect a selective bias to include the
higher risk patients in the extra-ana
tomic group. The operative complica-

EXTRA-ANATOMIC BYPASS

tion rate remained below 10%, aided
by careful postoperative observation
and nursing in the surgical intensive
care unit. The only factor that was
found to affect primary graft patency
was whether the patient continued to
smoke; most of those who required
thrombectomy to maintain graft pat
ency were smokers. The presence of
diabetes, the status of distal run-off
and the indications for operation did
not affect the patency rate.
Several factors may account for the
increased patency of crossover femo
ral grafts compared with other grafts.

This is the shortest bypass graft, so
there is less thrombogenic surface
exposed to blood elements. Bias was
introduced in that this procedure was
preferred for young people with uni
lateral disease. In addition, the statis
tical lack of improvement in patency
in the unilateral group may indicate
that the disease process is not truly
unilateral. The diagnosis of unilateral
disease was made on the basis of
single-plane angiography; no pres
sure measurements were made. The
lack of improvement in patency may
indicate the missed diagnosis of donor

PATENCY (%)

FIG. 1. Life-table analysis of femorofemoral grafts up to 36 months after implantation.
Numbers of patients followed up are indicated below line.

PATENCY (%)

►

MONTHS FOLLOW-UP
FIG. 2. Life-table analysis of axillounifemoral (crosses) and axillobifemoral (dots) grafts
up to 36 months after implantation. Numbers of patients followed up are indicated above
and below lines.

i

limb stenosis. Crossover grafting may
be recommended when unilateral iliac
artery stenosis is confirmed angiographically by multiple views and
pressure studies are normal after pa
paverine infusion.12 In no instance in
our series was the donor limb lost or
threatened secondary to the arterial
procedure.
As described by others,3 the paten
cy of axillobifemoral bypass grafts is
greater than unilateral axillofemoral
grafts. The suggested reason for this
is that the long arm of the axillofemor
al component is exposed to higher
flow rates,5 when outflow is doubled
by run-off into both legs. Graft size did
not correlate with patency in our
study. Statistical significance was not
attained when patency rates of axil
lofemoral and axillobifemoral bypass
grafts were compared, but a trend was
noted. From these data we recom
mend that symptoms on both sides be
carefully assessed and that the selec
tion of operation be governed by the
symptoms. If there is bilateral isch
emia or cause to believe that contra
lateral ischemia may develop, then
axillobifemoral grafting is indicated.
The limb salvage rate (82%) was
higher than the primary graft patency
rate (66%) and not all amputations
occurred in patients with occluded
grafts, indicating that long-term graft
patency is not necessary to prevent
amputation. The indications for oper
ation were a determinant of the even
tual amputation rate but did not affect
graft patency. Patients suffering from
claudication had fewer symptoms
(5%) than those who underwent graft
ing for other reasons (18%).
Our recommendations for extraanatomic bypass grafting are as fol
lows:
• Patients should be encouraged
to stop smoking because of its
adverse effect on graft patency.
• Extra-anatomic bypass graft
ing, although historically less durable
than anatomic reconstructions, is ac
ceptable in high-risk patients or in
CJS, VOL. 32, NO. 2, MARCH 1989
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patients with truly unilateral disease.
It offers an acceptable mortality and
morbidity for limb salvage to even
high-risk patients.
• For patients of all ages with
unilateral disease, a crossover femoral
graft may be a reasonable alternative
to aortic procedures.
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OPERATIVE
NEUROSURGICAL
TECHNIQUES:
INDICATIONS,
METHODS AND RESULTS. 2 volume
set. Edited by Henry H. Schmidek and
William H. Sweet. 1601 pp. Illust.
Grune & Stratton, Inc., New York;
W.B. Saunders Limited, Toronto,
1982. $436.75. ISBN 0-8089-1439-1.

This comprehensive two-volume text is
the result of the wide acceptance of
Current Techniques in Operative Neuro
surgery, by the same editors.

This text details the indications for,
the surgical techniques and results of
many operative procedures of the cen
tral and peripheral nervous systems. As
well as updated chapters from the origi
nal volume, there are new chapters on
anesthesia, pediatric neurosurgery, sur
gery of the scalp and skull, head inju
ries, brain tumours, cerebrovascular dis
ease, functional neurosurgery, surgery
of the spinal column and cord and
operative treatment of lesions of the
cranial and peripheral nerves. The text
is noteworthy because not only are
standard techniques presented, but al
ternative methods and approaches are
detailed.
Each chapter has been written by an
expert in his field, the majority of the
contributors being surgeons from the
US or Canada and a few distinguished
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European surgeons. Besides neurosur
geons, the contributors include distin
guished otolaryngologists, orthopedists,
ophthalmologists, cardiothoracic sur
geons, anesthesiologists and radiolo
gists. As a result, an admirable balance
and depth of coverage of each topic has
been achieved.
The two volumes are beautifully pro
duced, profusely illustrated and provide
many key references. Every neurosur
geon, and many surgeons in related
fields, will find this book of value.
S.J. Peerless, MD, FRCSC
C.G. Drake Professor o f Neurosurgery,
Chairman, Division o f Neurosurgery,
The University o f Western Ontario,
London, Ont.

PATHOLOGY OF THE TESTIS AND
ITS ADNEXA. Edited by Aleksander
Talerman and Lawrence M. Roth. 263
pp. Illust. Churchill Livingstone, Edin
burgh; Academic Press Canada, Don
Mills, Ont., 1986. $79.95. ISBN
0-443-08351-7.

This is volume 7 in the series “Contem
porary Issues in Surgical Pathology” . It
is written by 19 authors, most of them
well-known pathologists.

It covers extremely well the various
aspects of testicular tumours, including
their epidemiology, histopathology, ul
trastructure, pathogenesis, comparative
pathology and clinical management.
The five chapters on the pathology of
tumours of the testicle and its adnexa
are excellent and current. The different
types of tumour are well described and
illustrated by high-quality black and
white photographs. The immunohistochemistry and the detection of interme
diate filament proteins of germ cell
tumour by the immunofluorescent
method are also discussed. These rela
tively new techniques of investigation,
although in the initial stages of devel
opment, have proven to have practical
value in the correct typing of testicular
germ cell tumours. The clinical man
agement of testicular cancer and the
value of serologic tumour markers such
as human chorionic gonadotropin, afetoprotein and others in staging and
monitoring the therapy of germ cell
neoplasms are clearly presented. The
information provided will be important
and helpful to the practising patholo
gist not specialized in neoplastic disease
of the male genitourinary system when
reporting on a testicular tumour. One
excellent chapter discusses the pathocontinued on page 120
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Abdominal Aortic Aneurysm:
Consequences of a Positive Family History
C. William Cole, MD, FRCSC; Graeme G. Barber, MD, FACS, FICS, FRCSC;
Adrien G. Bouchard, MD, FRCSC; Neil V. McPhail, MD, FRCSC; Celine Roberge;
Walter G. Waddell, MD, FACS, FRCSC; James L. Wellington, MD, FACS, FRCSC
To assess the prevalence of coexisting abdominal aortic aneurysm (AAA) within
certain families, a retrospective review was carried out of patients who had
undergone AAA repair over a 5-year period. Contact was made with 305 families
(52%) and a positive history of an affected, first-degree relative was obtained in 34
(11%). A known AAA was reported to affect approximately 20% of siblings at risk
when the proband had an affected parent or sibling. Siblings of patients with an
affected first-degree relative represent a high-risk group that may benefit from a
screening program for earlier detection and elective management of AAA.

;

Dans le but d’evaluer la prevalence, au sein de certaines families, d’anevrismes de
l’aorte abdominale (AAA), on a procede a une etude retrospective des patients qui
avaient subi une reparation d’un AAA au cours d’une periode de 5 ans. Des contacts
purent etre etablis avec 305 families (52%); dans 34 cas (11%), on obtint une histoire
d’un diagnostic positif chez un parent du premier degre. Un AAA connu affectait
environ 20% des freres et soeurs a risque quand un proposant avait un pere, une
mere, un frere ou une soeur qui en etait atteint. Les freres et soeurs des patients qui
ont un parent du premier degre affecte par cette maladie constituent un group a
risque qui pourrait beneficier d’un programme de depistage visant a detecter de
facon precoce les AAA et a les traiter de fajon non urgente.

he poor results of treatment for
ruptured abdominal aortic an
eurysm (AAA) make its early detec
tion and elective surgical repair the
ideal method of management. Be
cause they are often asymptomatic
and may be difficult to detect by
physical examination alone, many
AAAs go unnoticed until they rup

T

ture. Abdominal aortic aneurysm
has been likened to a “U boat in the
belly” because it is a silent killer
that can be detected by ultrasonog
raphy.1 Recognition of a high-risk
group for AAA could lead to earlier
detection and treatment by screen
ing with ultrasonography, and this
may reduce the number of ruptures.
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Reprint requests to: Dr. C. Wm. Cole, Ste. 632, CPC, Ottawa Civic Hospital, 1053 Carling Ave
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The tendency for AAA to occur in
families23 may be one means of
identifying high-risk individuals
who might benefit from a screening
program. To evaluate the potential
for such a program we carried out a
review of the families of patients
known to have undergone repair of
AAA.

Methods

Patients treated for AAA at the
Ottawa Civic Hospital or Ottawa
General Hospital between January
1981 and December 1986 were
identified by a computer search.4
The patients (or their family) were
contacted by telephone and, after
they had given verbal consent to
provide information, they completed
a brief questionnaire which helped
to establish whether or not any
family member was known to have
an AAA. Care was taken to conduct
the telephone interview in lay
terms, but no other term was sub
stituted for “aneurysm” . When a
family member other than the pro
band was found to have an AAA, a
detailed family tree was constructed
to illustrate that person’s relation
ship to the proband, and the even
tual outcome of treatment. It was
assumed that the probands would
know of AAA among other family
members if it had been detected,
operated upon, or if death had been
CJS, VOL. 32, NO. 2, MARCH 1989
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attributed to aneurysm rupture. No
attempt was made to address the
question of undetected AAA among
family members.

Results
A total of 586 patients who had
undergone repair of an AAA were
identified, and it was possible to
obtain information by telephone in
terview from 305 (Fig. 1). Compli
ance with our request was complete
in all cases. Only one family report
ed a relative with a cerebral aneu
rysm. Only one affected offspring of
a proband was reported (no. 1, Fig.
2). Of 41 positive responses, AAA
among the first-degree relatives of
probands (parents, siblings or off
spring) was found in 34 cases. The
details of these relationships are
illustrated as family trees in Fig. 2;
family no. 29 had two probands.
Seven AAAs reported during the
interview were shown to have been
in distant relatives or family mem
bers without direct kinship to the
proband and were excluded from
the analysis (nos. 5, 9, 22, 26, 28,
33, 38).
Of the 34 families that had a
family history consisting of a pro
band and at least one other affect
ed, first-degree relative, 20% of the
siblings had an AAA (Table I). In 16
families in which the first-degree
relative was a parent, AAA affected
18% of siblings (Table II). Overall,
AAA affected male siblings more
often than females, but this rela
tionship was most evident among
the siblings of probands with a
positive parental history.

which lack scientific rigour. Never
theless, data from studies such as
this serve a useful purpose by act
ing as signposts, if not benchmarks,
for further study. In this series, we
accepted the evidence given in a
telephone interview regarding AAA
in relatives, and made the assump
tion that probands and their fami
lies are well informed about AAA
occurring in their relatives. Inher
ent in this assumption was the fact
that undetected AAA would not be
reported, and uncertainty on the
part of the family about “aneu
rysm” could lead to a degree of
over-reporting. Even with these
weaknesses, our data are similar to
those generated by others using
patient interview techniques. In a
similar study, carried out as a coop
erative effort by the Puget Sound
Vascular Society, in which patients
with AAA were asked to complete a
questionnaire and the results were
compared with those of a control
group, the estimated relative risk
for AAA among persons with an
affected first-degree relative was

11.6.2 In their study a history of
AAA in a parent appeared to confer
about the same excess risk as a
history of AAA in a sibling.2
Age and sex are important fac
tors in the development of AAA
which is rare before the age of 50
years and occurs predominantly in
men.5 In our study the number of
men affected by AAA was also
greater than the number of women,
but the number of women was not
insignificant. Our data support the
suggestion that all siblings of a
patient with an AAA and a positive
parental/sibling history are at in
creased risk and should be advised
to undergo a periodic screening
regardless of sex.
The death rate for ruptured AAA
compared with the excellent results
with elective management presents
a compelling argument for early
detection and repair. In many cases,
symptoms from an AAA may not
develop before it ruptures and the
death rate then exceeds 50% and
associated morbidity, usually from
multiorgan failure, may reach 80%.6

Discussion
Our data were generated by
“soft” techniques, which take ad
vantage of information that is readi
ly available at little or no cost, but
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FIG. 1. Results of telephone interview to assess occurrence of abdominal aortic
aneurysm (AAA) among relatives of patients with AAA.

ABDOMINAL AORTIC ANEURYSM

In contrast, elective repair of AAA
carries a combined morbidity and
mortality of less than 5%.7 Patients
who survive the surgical procedure
to repair an AAA have a life expec
tancy similar to that of the general
population.89 The frequency of
AAA appears to be increasing,1011
perhaps because the population as a
whole is older or because detection
of AAA is more common. Recogni
tion of a previously undetected AAA

by ultrasonography or computed
tomography of the abdomen is not
uncommon and also may play a role
in the apparent increasing frequen
cy. The unreliability of physical
examination alone in detecting
asymptomatic AAA is well recog
nized, and the potential for early
detection by ultrasonography has
led some1 to recommend that every
one over 50 years of age should
undergo periodic ultrasonography

of the abdomen. The investigation
is inexpensive and noninvasive, it is
widely used to c h a ra c te riz e
AAA,1213 and in obese subjects has
been recommended14 as part of the
routine physical examination.
The wisdom of these recommen
dations has not been tested by
population studies, but these are
clearly needed. Our data support
the adoption of ultrasonography as
a screening measure to detect AAA

surgery.

.

T a b le 1 A b d o m in a l A o rtic A n e u ry s m (A A A ) in F irs t-D e g re e R e la tiv e s o f 3 4 P ro b a n d s
R e latio n to
proband
M o th e r
F ather
S is te r
B ro th e r
T o ta ls

N o. at
risk

W ith AAA,
no. (% )

R upture,
no. (% )

D eath
w ith ru p tu re,
no. (% )
0
5 (1 0 0 )
4 (1 0 0 )
9 (1 0 0 )

34
34
83
86

11 (32)
7 (2 1 )
1 4 (1 7 )
20 (2 3 )

1 O)
5 (7 1 )
4 (2 9 )
9 (4 5 )

237

*5 3 (2 2 )

19 (3 6 )

'O n e fe m a le p ro b a n d had an a ffe c te d son.

18 (9 5 )

T o ta l
d e a th s ,
no. (% )

T a b le II. P ro b a n d s W h o s e P a re n ts W e re
A ffe c te d
R e la tio n to
p ro b a n d

No.

W ith AAA,
no. ( % )

0
7 (7 1 )
5 (3 6 )
10 (5 0 )

M o th e r
F a th e r
S is te r
B ro th e r

16
16
27
27

11 (6 9 )
7 (4 4 )
4 (1 5 )
6 (2 2 )

22 (4 2 )

B o th p a re n ts o f n o s .
a ffe c te d w ith A A A .

10

and
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in high-risk individuals, specifically,
siblings of probands with a positive
parental/sibling history of AAA. It
seems reasonable to begin screen
ing this group after the age of 50
years.
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logic changes in testicular cancers after
chemotherapy, an area rarely covered in
standard textbooks of pathology. To
complete the book, a chapter on mor
phologic changes of the testicle and
male infertility after systemic chemo
therapy is included.
This small, easy-to-read book repre
sents an up-to-date complete review of
both pathological and clinical aspects of
testicular tumours. It is a book that
every practising pathologist and urolo
gist should have in the office for con
sultation.
Gia-Khanh Nguyen, MD, FRCPC
Department o f Pathology,
W.C. Mackenzie Health Sciences Centre,
University o f Alberta,
Edmonton, Alta.

PERSPECTIVES IN RADIOLOGY.
Edited by Clyde A. Helms. 166 pp.
Illust. Quality Medical Publishing,
Inc., St. Louis, Mo., 1988. $171.00.
ISSN 0896-873-X.

Dr. Charles Drake, the noted neurosur
geon, has commented “We’re now in
the age of imaging.’’ Not surprisingly,
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we are also in the age of the imaging
journal. Radiologists are inundated with
peer-reviewed journals in radiology and
its many subspecialties, with quarterly
reviews, journals offering continuing
medical education and “throw-away”
publications sponsored by manufactur
ers. Perspectives in Radiology is a hard
cover hybrid of a journal and textbook.
The text seeks a niche between the
academic and clinical sectors by offer
ing observational-type articles which
were common 20 years ago but which
the rigours of peer-review have pushed
on to the endangered species list.
The distinguished radiologists from
the University of California in San Fran
cisco, who form the editorial board for
the text, have invited comment from a
general surgeon on the topic of sonog
raphy in acute appendicitis and an or
thopedic surgeon on the role of mag
netic resonance imaging in internal de
rangements of the knee. Other features
are an exchange between a radiologist,
lawyer and ethicist on contrast media
and the presidential address, “On being
a complete professional” , from the
1987 annual meeting of the Congress
of Neurological Surgeons.
Although I have no quarrel with the
quality of the material in this work, it is
not clear to whom the book is directed.

Those seeking editorial comment, in
formed opinion or advice on “how to do
it” can find these in the leading peerreviewed publications. Readers seeking
in-depth reviews are well served by
quarterly journals and computer-assist
ed literature searches.
The editor asks in the preface “Does
a need exist for this publication?”. I
think not, but I am willing to be proved
wrong.
Ian Hammond, MD, FRCPC
Department o f Radiology,
Ottawa General Hospital,
501 Smyth Rd„
Ottawa, Ont.

K1H8L6

SURGICAL PATHOLOGY. 2 volumes.
2nd edition. W.F. Coulson. 1824 pp.
Illust. J.B. Lippincott Co., Philadel
phia, 1988. $260.00. ISBN 0-39750609-0 (set).

This revised reference book is truly
comprehensive and current. No subject
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Transiliac Bypass for Infected Femoral
End of an Aortofemoral Graft
W. Brzezinski, MD; J.C. Callaghan, OC, MD, FRCSC
Infection of an aortofemoral fabric graft is among the most serious complications of
vascular surgery and necessitates removal of the graft. The authors chose a
transosseal (iliac bone) approach to permit a new graft to be carried down to the
periphery without the risk of contamination or pressure on it from the patient’s
position. They performed th is procedure in a 71-year-old man. He underwent a
transiliac bypass before the infected limb of an aortobifemoral graft was removed. He
was well 11 months after the operation and the graft was functioning well with no
evidence of infection.

L’infection d’un greffon prosthetique de l’aorte femorale constitue une des plus serieuses
complications de la chirurgie vasculaire; elle necessite le retrait du greffon. Les auteurs
ont choisi un abord transosseux (par l’os iliaque) pour permettre la realisation d’une
nouvelle greffe pratiquee en Peripherie, tout en evitant le risque de contamination ou la
pression exercee sur la greffe par la position du patient. Ils ont pratique cette intervention
chez un homme de 71 ans qui fut soumis a une derivation transiliaque avant le retrait de la
partie infectee de la greffe aortobifemorale. Onze mois apres l’operation, le patient se
portait bien et la greffe fonctionnait, sans signe d’infection.

►

i
►
►

►
►

►

I

►

G

raft infection is the most seri
ous complication of recon
structive vascular surgery with
respect to death and limb loss.14
It presents the vascular surgeon
with the greatest challenge to
judgement and technique. Since
1952, when Freeman and Leeds5
reported the use of endarterectomized superficial femoral artery for
a femorofemoral bypass, many
other extra-anatomic bypasses have
been described.6-9 In this paper we
describe the use of a transosseal
(iliac bone) ap p ro ach in a
71-year-old man to permit revascu-

negative). Since then he had experi
enced periodic serous discharge
from the right groin and had had
serous collections aspirated on sev
eral occasions. In October 1987,
while he was in Japan, he noticed
that purulent material was draining
from the right groin. He was admit
ted to the Cardiovascular and Tho
racic Surgery Service of the Univer
sity of Alberta Hospitals in Edmon
ton. Cultures of purulent material
grew /3-hemolytic Streptococcus.
Computed tomography and angi
ography (Fig. 1) showed that the
infection did not extend above the
inguinal ligament. The left limb of
the aortobifemoral graft was oc-

larization of the lower limb and to
bypass the infected groin.

Case Report
This 71-year-old man was healthy
except for severe aortoiliac disease
with disabling intermittent claudica
tion. He had undergone an aor
tobifemoral bypass with insertion of
a Dacron graft in 1973. Five years
later he required thrombectomy and
revision of the right limb of the
graft, which was followed by exci
sion of the seroma (cultures were

►

From the Department o f Surgery, University o f Alberta, Edmonton, Alta.
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►

Presented at the 10th annual meeting of the Canadian Society for Vascular Surgery, held in
conjunction with the 57th annual meeting o f the Royal College o f Physicians and Surgeons o f
Canada, Ottawa, Ont.. Sept. 25, 1988
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Accepted for publication Nov. 18, 1988
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Reprint requests to: Dr. J.C. Callaghan, Department o f Surgery, University o f Alberta Hospital
Edmonton, Alta. T6C 2B7

FIG. 1. A ngiogram of infected graft.
There was no evidence of infection
above level of inguinal ligam ent. Left
limb of graft is occluded. Peripheral
run-off from right limb is good.

►

>
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eluded. The graft-dependent right
lower extremity demonstrated good
peripheral run-off.
At operation through an extraperitoneal approach, the right
limb of the aortobifemoral graft was
transected just distal to the bifurca
tion and the distal end ligated. The
proximal end was anastomosed endto-end to a new 8-mm Hemashield
graft (Meadox Medical Inc., Oak
land, NJ). The new graft was
brought through a drilled “win

dow” in the right iliac bone (Figs. 2
and 3), passed laterally to the in
fected groin and anastomosed endto-side to the middle portion of the
right superficial femoral artery (Fig.
4). One week later the infected right
limb of the aortobifemoral graft was
removed. Cultures of the graft ma
terial grew the two strains of coagulase negative Staphylococcus. The
patient was treated with appropriate
antibiotics and local wound care.
The groin wound healed complete-

ly, and follow-up angiography dem
onstrated that the graft was func
tioning well (Fig. 5).

FIG. 4. Right limb has been transected
distal to bifurcation and new graft
anastomosed end to end. New graft is
carried through window in iliac bone
and anastomosed end to side to super
ficial femoral artery.
FIG. 2. Diagram showing position of window drilled in iliac bone through which
new graft is passed.

FIG. 3. Roentgenograms showing hole drilled in right iliac bone to accomodate
bypass graft.
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FIG. 5. Follow-up angiogram shows
new graft functioning well.

TRANSILIAC BYPASS FOR GRAFT INFECTION

Six months later, the patient un
derwent femorofemoral crossover
grafting because of intermittent

FIG. 6. Diagram showing femorofem
oral crossover graft inserted to allevi
ate intermittent claudication of left
lower extremity caused by occlusion of
left limb of graft.

claudication of the left lower ex
tremity (Fig. 6). Follow-up angiog
raphy again demonstrated well
functioning grafts (Fig. 7). The pa
tient was asymptomatic 5 months
after the last procedure.

3.

Discussion

4.

Vascular graft infection in the
groin necessitates removal of the
infected portion.310 Simultaneous
revascularization of the affected ex
tremity can be accomplished in
many ways. Axillofemoral bypass is
the most common method, but the
graft is prone to occlusion from
prolonged compression when the
patient is sleeping. Its extension to
the popliteal or tibial arteries de
creases long-term patency.11-12 Ob
turator bypass is an effective meth
od of lower extremity revasculariza
tion.9-13-17 However, it makes subse
quent revascularization of the oppo
site extremity more complicated be
cause of repeated intra-abdominal
and retroperitoneal dissection.
We chose a new approach to the
problem of extra-anatomic revascu
larization of the graft-dependent
limb, using transiliac bypass. To the
best of our knowledge this has
never before been reported. The
procedure appears to be safe and
effective and is technically simple to
perform. Furthermore, it offers an
excellent, easily accessible inflow
source should future bypass to the
opposite extremity be necessary.
Long-term follow-up of a greater
number of patients is needed to
determine the potential of this route
compared with others.
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R enal Oncocytoma in Pregnancy: a Case
Report
William D. Fraser, MD, FRCSC;* Manon Auger, MD;t Ronald M. Onerheim, MD, FRCPC$

Oncocytoma is an uncommon renal tumour and this is the first report of such a tumour
occurring in a pregnant woman. Optimal treatment is nephrectomy and the prognosis is
usually good, though metastasis has been reported. It is unknown whether pregnancy
alters tumour behaviour or the prognosis.

L’oncocytome est une tumeur renale rare; il s’agit de la premiere description d’une telle
tumeur a survenir chez une femme enceinte. La nephrectomie est le traitement optimal et
le pronostic est habituellement favorable, bien que des metastases aient deja ete
rapportees. On ignore si la grossesse peut modifier le comportement de la tumeur ou le
pronostic.

enal oncocytoma is a rare tumour
which has been recognized as a
distinct pathological entity only in the
last decade. We describe the case of a
pregnant woman who had a renal
oncocytoma. We believe this is the
first such case to be reported.

R

Case R eport
A 3 1 -year-old black Canadian
woman of Haitian origin presented at
23 weeks’ gestation complaining of
severe back pain on the right side,
radiating to the ipsilateral thigh and
shoulder. A transient episode of simi
lar pain had occurred 2 weeks earlier.
Her first pregnancy was a twin gesta
tion which culminated in vaginal de

livery at 37 weeks, after induction for
severe pre-eclampsia. She had no re
cent complaints of fever, chills, dysuria or hematuria and no history of
urinary tract infection or tuberculosis.
Abdominal examination revealed a
nontender uterus which was appropri
ate size for gestational age. Fetal
heart tones were present. There was
no costovertebral angle tenderness.
Her blood pressure was 1 0 0 /6 5 mm
Hg.
Urinalysis and microscopic exami
nation of the urine gave normal re
sults. Hematologic investigation
yielded the following: hemoglobin
level 98 g /L ; hematocrit 0.27; leuko
cyte count 5.9 X 109/ L ; platelets 289
X 109/ L ; mean corpuscular volume
84 fl; mean corpuscular hemoglobin

*Department o f Obstetrics and Gynecology, Foothills Hospital and University o f Calgary,
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concentration 34 g /L ; sickle cell prep
was negative. The serum sodium,
potassium, chloride, uric acid, creati
nine, urea nitrogen and iron levels
were within normal limits as was the
total iron binding capacity. The serum
ferritin level was 15.8 jug/L. The
purified protein derivative test (5TU)
was negative. The creatinine clear
ance, based on a 24-hour urine collec
tion, was 93 m l/m in. Cytologic exam
ination of the urine showed no malig
nant cells and urine culture was nega
tive.
Abdominal ultrasonography re
vealed an echogenic zone on the
upper pole of the right kidney measur
ing approximately 10 X 12 cm. A
single-shot intravenous pyelogram
(10-minute film) confirmed the pres
ence of a mass filling the upper pole of
the right kidney. The left kidney
appeared normal. Renal arteriography
was attempted but abandoned for
technical reasons. The chest x-ray
film was normal.
On day 6 after admission to hospi
tal, the patient received 2 units of
packed red blood cells and then under
went a right radical nephrectomy
through a subcostal incision. A large
mass was present in the right kidney
but there was no gross evidence of
surrounding disease. She had a
smooth recovery and was discharged
from hospital on postoperative day 9.
Routine examination at 31 weeks'
gestation revealed, for the first time
during the pregnancy, an elevated
blood pressure of 1 3 0 /9 0 mm Hg.
The patient was readmitted at 34
weeks’ gestation with severe head-

RENAL ONCOCYTOMA IN PREGNANCY
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ache; blood pressure was 180/112
mm Hg. Findings of chest and heart
examinations were within normal lim
its. Deep tendon reflexes were slightly
increased, but there was no clonus.
Fetal heart sounds were present and
the cervix was long and closed. The
following laboratory results were ob
tained: semiquantitative test for uri
nary protein 4+; hemoglobin level
114 g /L ; hematocrit 0.35; leukocyte
count 8.5 X 109/L ; platelets 223 X
109/L ; serum creatinine level 88.4
/umol/L; serum sodium 138 mmol/L;
serum potassium 5.2 m m ol/L and
serum carbon dioxide 24 mmol/L.
A diagnosis of severe pre-eclampsia
was made. The patient was stabilized
with an infusion of magnesium sulfate
and, after a failed induction, under
went a low transverse cesarean sec
tion to deliver a live female infant
weighing 2160 g.
Her convalesence was complicated
by bouts of severe hypertension which
were brought under control with a methyldopa. The urinary creatinine
clearance on postoperative day 8 was
1.1 m l/s. The patient was discharged
on postoperative day 10 and was well
at her 1-year follow-up.

Pathological Features

►

-

►

►

The operative specimen consisted
of a right kidney and ureter. The
former, measuring 12.5 X 7 X 4.5 cm,
was deformed by a mass occupying
the anterior aspect of the upper pole;
the renal capsule was intact.
The round solid tumour measured
12.5 X 12 X 11.5 cm, appeared
encapsulated and compressed the sur
rounding renal parenchyma, imping
ing on the renal pelvis but without
invasion into the surrounding struc
tures. It had a uniform appearance
and was vascular with a tan coloura
tion. There were no areas of hemorrh
age or necrosis.
On microscopic examination the
tumour was composed of uniform

polygonal cells with an abundant,
strikingly eosinophilic granular cyto
plasm and well-defined cytoplasmic
borders. The cells were arranged in a
predominantly alveolar pattern sup
ported by a prominent delicate vascu
lar framework. Nuclear pleomorphism was absent, nucleoli were not
prominent and mitotic figures were
lacking. The margin of the tumour, a
thin fibrous capsule, was not invaded.
The electron microscopic appear
ance was typical of oncocytoma. The
cytoplasm of the neoplastic cells was
filled with mitochondria, to the virtual
exclusion of other organelles, and
there were no fat vacuoles found (Fig.
1). Many mitochondria had tubulovesicular christae; others showed the
characteristic stacked mitochondrial
christae (Fig. 2).

who had oncocytoma; 4 died of meta
static renal carcinoma, which demon
strated anisocytosis and nuclear irreg
ularity in the metastases. They pro
posed a grading system for on
cocytoma, based on cellular differenti
ation, and suggested that grading
may be useful in determining progno
sis.
More recently, Lewi and associates4
described two patients with well-dif
ferentiated or grade 1 renal on
cocytoma in whom metastatic disease
developed, suggesting that the ability

Discussion
Hamperl,1 in 1962, coined the term
“oncocyte” to describe a special type
of tumour cell arising from metaplas
tic transformation, mainly in the sali
vary, parathyroid and thyroid glands.
“The cytoplasm is more or less dense
ly filled with...acidophilic granules....
Electron microscopy studies showed
that the cytoplasm is extremely rich in
mitochondria.”1
In 1976, Klein and Valensi2 report
ed on 13 proximal renal tumours
which they called proximal tubular
adenomas; these tumours had on
cocytic features, but they also referred
to them as oncocytomas. Their mor
phology and behaviour were de
scribed. The clinical presentation was,
in most cases, silent. The tumours
were discovered incidentally during
the work-up for another condition.
Based on the excellent long-term
survival of affected patients after ne
phrectomy, Klein and Valensi1 sur
mised that these tumours were be
nign. However, it has become appar
ent that this is not always so. Lieber
and colleagues3 described 90 patients

FIG. 1. Electron photomicrograph of
typical tumour cell of renal oncocytoma,
with mitochondria filling cytoplasm
(original magnification X 7000).

FIG. 2. Electron photomicrograph of
mitochondria with stacked cristae (ar
rows) (original magnification X 17 500).
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to metastasize may not be related to
histologic appearance.
Renal tumours presenting in preg
nancy are rare. Ney and colleagues,5
in 1971, described a pregnant woman
with a renal tumour containing gran
ular areas which were probably on
cocytic. However, that tumour also
contained clear cell areas, as well as
sites o f hemorrhage and necrosis. By
modern consensus it would be diag
nosed as renal cell carcinoma on the
basis o f the presence of clear cell areas
and on size (9 cm).
The gross, light microscopic and
electron microscopic features of the
tumour in our patient were consistent
with those described in the literature
for renal oncocytoma.2-6
As with other neoplasms, the
growth o f some renal tumours may be
influenced by the concentrations of
ambient sex steroids. In 1948, Kirkman7 demonstrated that estrogens
may induce renal carcinomas in ham
sters. Occasional therapeutic re
sponses to medroxyprogesterone ace
tate therapy have been observed in
patients with advanced renal cell car
cinoma. In an attempt to assess the
mechanism o f response in one such
patient, Cummings and associates8
obtained tissue cultures of renal carci
noma cells and exposed them to vary
ing concentrations o f both medroxy
progesterone acetate and estradiol
cypionate. Neither hormone was
found to influence tumour growth in
tissue culture so they reasoned that
the patient’s response was based on
some other mechanisms.
The effect o f hormonal factors on
the growth o f renal oncocytoma has
not been studied. As noted, the acute
clinical presentation seen in our pa
tient is unusual and one may specu
late as to whether this presentation
was related to a sudden change in
tumour size, perhaps hormonally me
diated.
Current preoperative diagnostic
techniques cannot accurately distin
guish between renal oncocytoma and
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renal carcinoma. Although angio
graphic features typical of on
cocytoma have been described,9 renal
cell carcinoma may display identical
characteristics. Fine-needle aspiration
cytology o f renal oncocytomas has
been reported;10 however, as renal cell
carcinoma may also contain inter
posed areas of oncocytes in a mosaic
pattern, this technique is not reliable
in differentiating the two. To achieve
accurate diagnosis and minimize the
risk o f recurrence for pregnant pa
tients with suspected renal on
cocytoma, nephrectomy is the treat
ment of choice.
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1 - Intra-abdominal infections such as peritonitis
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Staphylococci, penicillinase producing and
non-producing
Streptococci excluding enterococci
Gram negative (beta-lactamase producing and
non-producing strains)

E. coli
Klebsiella species (including K. pneumoniae)
Proteus, indole positive and negative
Haemophilus influenzae
Providencia species
Anaerobes

Bacteroides fragilis
MEFOXIN® may also be appropriate for the
treatment of infections involving susceptible
strains of both aerobic and anaerobic bacteria.
MEFOXIN® is not active against Pseudomonas,
most strains of enterococci, many strains of
Enterobacter cloacae, and methicillin-resistant
staphylococci and Listeria monocytogenes.
Clinical experience has demonstrated that
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but, in the majority of surgical procedures, does
not reduce the in cid e n ce o f subsequent
infection.
If signs of postsurgical infection should appear,
specimens for culture should be obtained for
identification of the causative organism(s) so
that appropriate therapy may be instituted.

CONTRAINDICATIONS
MEFOXIN® is contraindicated in persons who
have shown hypersensitivity to cefoxitin or to
the cephalosporin group of antibiotics.

WARNINGS
Before therapy with MEFOXIN® is instituted,
careful inquiry should be made to determine
whether the patient has had previous hyper
sensitivity reactions to MEFOXIN®, cephalo
sporins, penicillins or other drugs. MEFOXIN®
should be given with caution to penicillinsensitive patients.
There is some clinical and laboratory evidence
of p a rtia l c r o s s - a lle r g e n ic ity between
cephamycins and the other beta-lactam anti
biotics, penicillins and cephalosporins. Severe
reactions (including anaphylaxis) have been
reported with most beta-lactam antibiotics.
Pseudomembranous colitis has been reported
with virtually all antibiotics. This colitis can
range from mild to life threatening in severity.
Antibiotics should therefore be prescribed with
caution in individuals with a history of gastro
intestinal disease, particularly colitis. It is
important to consider a diagnosis of pseudo
membranous colitis in patients who develop
diarrhea in association with antibiotic use. While
studies indicate that a toxin produced by
Clostridium difficile is one primary cause of
antibiotic-associated colitis, other causes
should also be considered.
Any patient who has demonstrated some form of
allergy, particularly to drugs, should receive
antibiotics including MEFOXIN® with caution.
If an allergic reaction to MEFOXIN® occurs,
administration of the drug should be discon
tinued. Serious hypersensitivity reactions may
require treatment with epinephrine and other
emergency measures.

PRECAUTIONS
The total daily dosage should be reduced when
MEFOXIN® is administered to patients with
transient or persistent reduction of urinary
output due to renal insufficiency (see DOSAGE
AND ADMINISTRATION) because high and
prolonged serum antibiotic concentrations can
occur from usual doses.
In patients treated with MEFOXIN® a false
positive reaction to glucose in the urine may
occur with Benedict's or Fehling's solutions but
not with the use of specific glucose oxidase
methods.
Using the Jaffe Method, falsely high creatinine
values in serum may occur if serum concen
trations of cefoxitin exceed 100/rg/mL. Serum
samples from patients treated with MEFOXIN®
should not be analyzed for creatinine if with
drawn within two hours of drug administration.
Increased nephrotoxicity has been reported
fo llo w in g c o n c o m ita n t adm in istra tio n of
cephalosporins and aminoglycoside antibiotics.
The safety of MEFOXIN® in the treatment of
infections during pregnancy has not been
established. If the administration of MEFOXIN®
to pregnant patients is considered necessary, its
use requires that the anticipated benefits be
weighed against possible hazards to the fetus.
Reproductive and teratogenic studies have been
performed in mice and rats and have revealed no
evidence of impaired fertility or harm to the fetus
due to MEFOXIN®.
Cefoxitin has been observed in the milk of
nursing mothers receiving the drug.
Prolonged use of MEFOXIN® may result in the
overgrowth of non-susceptible organisms.
Repeated evaluation of the patient's condition is
essential and if superinfection occurs during
therapy, appropriate measures should be taken.
Should an organism become resistant during
antibiotic therapy, another antibiotic should be
substituted.
In children 3 months of age or older, higher
doses of MEFOXIN® (10 0 m g/kg/day and

above) have been associated with an increased
incidence of eosinophilia and elevated SGOT.

ADVERSE REACTIONS
MEFOXIN® is generally well tolerated. Adverse
reactions rarely required cessation of treatment
and usually have been mild and transient.
Local Reactions
Thrombophlebitis has occurred with intra
venous administration. Some degree of pain and
tenderness is usually experienced after intra
muscular injections using water. Induration has
occasionally been reported.
Allergic
Maculopapular rash, urticaria, pruritus, eosino
philia, fever and other allergic reactions have
been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can
appear during or after antibiotic treatment.
Nausea and vomiting have been reported rarely.
Blood
Transient eosinophilia, leukopenia, neutropenia,
hemolytic anemia, and thrombocytopenia have
been reported. Some individuals, particularly
those with azotemia, may develop positive direct
Coombs tests during therapy with MEFOXIN®.
Liver Function
Transient elevations in SGOT, SGPT, serum
LDH, and serum alkaline phosphatase have
been reported.
Kidney
Elevations in serum creatinine and/or blood
urea nitrogen levels have been observed. As
with the cephalosporins, acute renal failure has
been reported rarely. The role of MEFOXIN® in
changes in renal function tests is difficult to
assess, since factors predisposing to prerenal
azotemia or to impaired renal function have
often been present.

should be employed and it is advisable to
monitor serum levels in patients with severe
impairment.
In adults with renal insufficiency, an initial
loading dose of 1 g to 2 g should be given. After
a loading dose, the following recommendations
for maintenance dosage may be used as a guide:
RENAL
FUNCTION

CREATININE
CLEARANCE
mL/mln

Mild
impairment
Moderate
impairment
Severe
impairment
Essentially
no function

DOSAGE AND ADMINISTRATION
MEFOXIN® may be administered intravenously
or in tra m u s c u la rly when required. (See
complete monograph on ADMINISTRATION
and RECONSTITUTION.)
TREATMENT DOSAGE
Adults
The usual adult dosage is 1 g or 2 g of
MEFOXIN® every 6 to 8 hours. Dosage and route
of administration should be determined by
severity of infection, susceptibility of the
causative organisms, and condition of the
patient. The usual adult dosages are shown in
the Table below.
Usual Adult Dosage
Type of
infection

Daily
Dosage

Frequency
and Route

Uncomplicated
forms* of in
fections such as
pneumonia,
urinary tract
infection, soft
tissue infection

3-4 g

1 g every 6-8 h
I.V. or I.M.

Moderately
severe or severe
infections

6-8 g

1 g every 4 h
or
2 g every 6-8 h I.V.

Infections
commonly
needing anti
biotics in higher
dosage (e.g. gas
gangrene)

12 g

2 g every 4 h
or
3 g every 6 h I.V.

■Including patients in whom
absent o r unlikely

bacterem ia is

Therapy may be started while awaiting the
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic
streptococcal infections should be maintained
for at least 10 days to guard against the risk of
rheum atic fever or glom erulonephritis. In
staphylococcal and other infections involving a
collection of pus, surgical drainage should be
carried out where indicated.
Adults with Impaired Renal Function
MEFOXIN® may be used in patients with
reduced renal function but a reduced dosage

FREQUENCY

50-30

1-2 g

every 8-12 h

29-10

1-2 g

every 12-24 h

9-5

0.5-1 g

every 12-24 h

<5

0.5-1 g

every 24-48 h

In the patient undergoing hemodialysis, the
loading dose of 1 - 2 g should be given after each
hemodialysis, and the maintenance dose should
be given as indicated in the Table above.
Neonates (Including Premature Infants), Infants
and Children (See WARNINGS fo r Neonates
under ADM INISTRATION in the com plete
monograph.)
Premature Infants
with Body Weights
Above 1500 g

20-40 mg/kg every 12 h I.V.

Neonates

01 week of age 20-40 mg/kg every 12 h I.V.
1-4 weeks of age
20-40 mg/kg every 8 h I.V.
Infants

1 month to 2 years
of age

20-40 mg/kg every 6 h or
every 8 h I.M. or I.V.

Children

20-40 mg/kg every 6 h or
every 8 h I.M. or I.V.

TREATMENT OF OVERDOSE
Other than general supportive treatment, no
specific antidote is known. MEFOXIN® can be
eliminated by dialysis in patients with renal
insufficiency.

DOSE

In severe infections, the total daily dosage in
infants and children may be increased to
200 mg/kg, but not to exceed 12 g per day.
MEFOXIN® is not recommended for the therapy
of meningitis. If meningitis is suspected, an
appropriate antibiotic should be used.
At present there is in s u ffic ie n t data to
recommend a specific dosage for children with
im paired renal fu n ctio n . However, if the
administration of MEFOXIN® is deemed to be
essential the dosage should be m odified
consistent with the recommendations for adults
(see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of
MEFOXIN® is recommended as follows:
Vaginal or abdominal hysterectomy and
abdominal surgery
2 g adm inistered intram uscularly or intra
venously just prior to surgery (approximately
one-half to one hour before initial incision).
The second and third 2g doses should be
administered at 2-6 hour intervals afterthe initial
dose.
Cesarean Section
The first dose of 2g should be administered
intravenously as soon as the um bilical cord has
been clamped. The second and third 2g doses
should be given in tra ve n o u sly o r in tra 
muscularly fo u r hours and eight hours after the
first dose.

AVAILABILITY
MEFOXIN® is supplied as sterile powder in
boxes of 10 vials:
3356 Ca - 1 g cefoxitin as sodium salt
3357 Ca - 2 g cefoxitin as sodium salt
Storage
MEFOXIN® in the dry state should be stored
below 30° C.
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Failure of Preoperative Cultures to
Predict Development of Staphylococcus
aureus Wound Infections After Cardiac
Surgery
G. Taylor, MD, FRCPC; R. Wiens, BScN; L. Miedzinski, MD
To assess the predictive value of preoperative surveillance cultures for the
postoperative development of Staphylococcus aureus wound infection, the findings
in 563 patients who underwent elective cardiac surgery were evaluated. One
hundred and forty-seven (26%) were found to be S. aureus carriers preoperatively.
Postoperatively, 11 S. aureus wound infections developed, 4 in patients whose
cultures were positive preoperatively and 7 in patients whose cultures were negative
preoperatively. The patient’s endogenous flora appears to be the source of only a
minority of such postoperative infections. The authors conclude that preoperative
surveillance cultures are not of value in predicting patients at risk for wound
infection after elective cardiac surgery.

On a etudie les donnees portant sur 563 patients de chirurgie cardiaque non urgente
afin d’evaluer la valeur previsionnelle d’une surveillance preoperatoire par culture
bacterienne sur le developpement postoperatoire des infections de plaie a Staphylo
coccus aureus. Cent quarante-sept patients (26%) furent trouves porteurs de S.
aureus avant Toperation. En postoperatoire, 11 infections de plaie a S. aureus
furent denombrees, 4 chez des patients dont les cultures etaient positives avant
l’operation et 7 chez des patients dont les cultures etaient negatives. La flore
endogene des malades semble etre a l’origine d’un petit nombre d'infections
postoperatives seulement. Les auteurs concluent que la surveillance bacterienne
preoperatoire ne permet pas de predire quels patients sont a risque de developper
une infection de plaie apres la chirurgie cardiaque non urgente.

espite the routine prophylactic
use of antibiotics, as many as
9% of patients who undergo cardiac
surgery continue to have wound
infection,1-4 the consequences of
which can be severe and include
such life-threatening problems as
endocarditis, pericarditis, mediasti-

D

nitis and bacteremia.5 Further, hos
pital stay may be prolonged. In a
study by Green and Wenzel,6 pa
tients who had a wound infection
after coronary artery bypass spent
14 days longer in hospital than
uninfected controls.
Staphylococcus aureus continues
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to be one of the commonest causes
of surgical infection in this popula
tion.45 In the preantibiotic era it
was shown that persons who car
ried S. aureus preoperatively were
more likely to have a S. aureus
wound infection after, and that the
infecting organism was usually of
the same phage type as the preoper
ative isolate.7 If it could be shown
that in patients who underwent car
diac surgery, preoperative carriage
of S. aureus was predictive of post
operative wound infection, then
eradication of the carrier state
might prevent many such infec
tions. This technique has been ap
plied with success in patients who
undergo long-term hemodialysis.8
For 12 months, we routinely ob
tained cultures preoperatively from
our patients scheduled to undergo
cardiac surgery to assess the predic
tive value of the cultures for the
postoperative development of S. au
reus wound infection.

Patients and Methods
All patients who underwent elec
tive cardiac surgery at the Universi
ty of Alberta Hospital, Edmonton,
between August 1986 and July
1987 were assessed. The nursing
staff obtained culture specimens
from anterior nares, chest skin and
groin skin of each patient within

PREDICTING POSTOPERATIVE WOUND INFECTION

48 hours of surgery by vigorously
rubbing these areas with cottontipped swabs. The specimens were
placed in transport media and sent
to the microbiology laboratory.
They were plated on mannitol salt
agar plates to enhance the recovery
of S. aureus and read at 48 hours.
Staphylococcal colonies were identi
fied using standard techniques.
Adult patients were given 1 g to
2 g of cephalothin or cefamandole
prophylactically 1 hour preoperatively and at 6-hour intervals for the
next 48 hours. (Some of the adult
patients were involved in a random
ized open study of cefamandole ver
sus cepalothin.) Pediatric patients
received cephalothin in a dose of 25

i

Table 1. Preoperative Cultures for
Staphylococcus aureus in Cardiac Surgery
Patients
Result
Negative all sites
Positive one or more sites
Nose negative
Nose positive

►

m g/kg prophylactically 1 hour preoperatively and at 6-hour intervals
postoperatively for two doses after
the test tube was removed.
The patients were followed up by
one of us (R.W.) from 48 hours
postoperatively until discharge.
Those who died within 48 hours
were omitted from our analysis.
Patients who underwent multiple
procedures were entered only on
the first occasion.
A surgical infection was diag
nosed by the following:
• Discharge of pus from the
surgical incision.
• Presence of erythema and serosanguineous discharge from the
incision associated with a positive
culture.
• Diagnosis of deep-seated infec
tion (endocarditis, purulent pericar
ditis, mediastinitis or sternal osteo
myelitis). Endocarditis was consid
ered to be surgically related in every
instance.
The results were analysed by
Fisher’s exact test.

No. (%)
416(74)
147 (26)
13
134

Table II. Breakdown of Cardiac Surgery Patients With Preoperative Cultures Positive for
Staphylococcus aureus
Age/sex/operation

►

►

►
►

►
►

Age, yr
< 1
1 -9
1 0 -1 9
2 0 -2 9
3 0 -3 9
4 0 -4 9
5 0 -5 9
> 60
Sex
Male
Female
Operation
Coronary artery bypass grafting
Valve replacement
Other cardiac

Total no.

No. (%)
positive cultures

23
61
20
16
25
49
126
243

4 (1 7 )
11(18)
7(35)
3 (1 9 )
6 (2 4 )
12(24)
29 (23)
75 (31)

392
171

104(27)
43 (25)

269
120
174

79 (29)
25(21)
43 (25)

Table III. Preoperative Cultures and Postoperative Staphylococcus aureus Wound Infections

►
►

Preop cultures

No.

Postop wound
infection, no. (%)

Negative
Positive

416
147

7(1.7)
4(2.7*)

Totals

563

►

►

*p = 0.3 by Fisher’s exact test.

11 (2.0)

Findings
Of the 563 patients in the study,
269 underwent coronary bypass,
170 valve replacement with or with
out coronary bypass and 163 other
cardiac procedures. Results of pre
operative cultures are shown in Ta
bles I and II. Overall, 26% (147)
were found to be carriers of S.
aureus. There was a trend for older
patients and for coronary bypass
patients to be carriers, though in
neither case was this trend signifi
cant. Nose cultures were by far the
most useful for identifying carriers,
cultures being positive in 91% of
patients ultimately found to be car
riers. Swabs from other sites were
only occasionally positive, and in
only 13 instances were they positive
when the nose culture was nega
tive.
Postoperatively, 29 patients
(5.2%) had a surgical infection.
Thirteen infections occurred at the
leg incision made for vein harvest
ing and 16 (7 superficial, 4 medias
tinitis, 2 purulent pericarditis and 3
endocarditis) at tissue exposed by
sternotomy or thoracotomy.
Organisms were cultured in 24 of
these 29 patients; in 5, cultures
were not submitted or were submit
ted and showed no growth. There
were 29 isolates in these 24 pa
tients. Staphylococcus aureus was
isolated 11 times (38%), Escherichia
coli 7 times, Streptococcus faecalis
6 times, Pseudomonas sp. twice,
Enterobacter sp. twice and Sta
phylococcus epidermidis once.
Table III shows the relationship
between preoperative isolation of S.
aureus and postoperative develop
ment of S. aureus wound infection.
Of the 11 postoperative isolates, 7
were obtained from patients who
were negative for S. aureus preoperatively and 4 from patients who
carried the organism preoperatively.
Preoperative cultures were not rou
tinely saved, therefore it was imposCJS, VOL. 32, NO. 2, MARCH 1989
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sible to undertake phage typing or
other tests of strain identity to
determine whether, in these four,
the pre- and postoperative strains
were identical.
Ten of the postoperative S. au
reus infections occurred in patients
receiving cephalothin prophylaxis
and 1 in a patient receiving cefamandole prophylaxis (who was also
positive preoperatively for S. au
reus).

Discussion
The follow-up for this study was
limited to the inpatient stay and so
precluded the detection of late in
fection. The wound infection rate of
5.2% was similar to or below that
seen in other studies.1-4 We were
able to confirm that, despite the use
of effective antistaphylococcal pro
phylaxis (cephalothin or cefamandole), S. aureus remains the single
commonest causative organism,
having been isolated from 38% of
infected patients. And though 10 of
11 S. aureus wound infections oc
curred in patients receiving ceph
alothin, this is likely a reflection of
its selection for routine use at our
institution, apart from patients in
volved in a comparison study with
cefamandole. Cephalothin and cefamandole are equivalent in their ac
tivity against S. aureus.9 Failure to
detect more instances of S. epidermidis infection is also likely a reflec
tion of the short follow-up in this
study compared with that of other
series.4’5
The source of the infecting or
ganisms in patients who undergo
clean surgery (such as cardiac sur
gery) has not been determined, but
likely derives from the human pop
ulation in the operating room dur
ing the procedure — either the
surgical team or the patient.10-12
Some hospitals used to culture the
anterior nares of the surgical team
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members regularly to detect S. au
reus carriers. Most hospitals have
discontinued this practice because
few carriers were shown to transmit
their organisms to patients, and
eradication of the carrier state was
neither easy nor permanent in many
cases.13 On the other hand, if the
patient was shown to be an impor
tant source of infecting organsims,
then even transient eradication
could be effective in reducing
wound infection rates. With the
advent of more effective agents to
eradicate the carrier state,1415 this
prospect is more attractive. Unfor
tunately, our study has shown that
the patient is the source of the
infecting organisms in only a minor
ity of instances. In only 4 of 11
cases (36%) in which S. aureus was
isolated from an infected wound,
was the patient shown to be a
carrier preoperatively, and even in
these 4 cases, since phage typing or
other tests to determine identity of
strains were not done, it cannot be
stated with certainty that the pa
tient was the source.
The statistical analysis of this
study could not exclude a mild
positive effect of the S. aureus
carrier state on postoperative infec
tion rates. To do so would have
required a much larger study popu
lation. Even a modest reduction in
wound infection would be of value
to patients, however, so the possi
bility of eradicating the carrier state
preoperatively should be explored
further. With the advent of topically
effective agents,14 this approach
could safely be applied to large
numbers of patients without the
need to target known carriers.

We thank members of the Division of
Cardiovascular Surgery for allowing us
to study their patients, the Division of
Diagnostic Microbiology who performed
the cultures and Mrs. L. Darragh who
typed the manuscript.
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Incidence and Importance of Bacteriuria
in Postoperative, Short-Term Urinary
Catheterization
J. Curtis Nickel, MD, FRCSC; Peter Feero, MD; J. William Costerton, PhD; Elda Wilson, RN
The frequency and importance of bacteriuria in patients requiring short-term
postoperative catheterization (24 to 48 hours) is unknown. From a prospective,
controlled study of 100 patients requiring catheterization postoperatively, the
authors determined that there was a definite risk (6%) of bacteriuria; however, a
symptomatic urinary tract infection developed in only 1% of the patients. There was
no advantage to using either a latex or silicone catheter. It appears that the risk of
symptomatic bacteriuria in this group of patients is very low when a closed urinary
drainage system is used under strict, sterile conditions of catheter insertion and with
meticulous ongoing catheter care.

On ignore la frequence et l’importance des bacteriuries chez les patients qui
necessitent un catheterisme postoperatoire de courte duree (de 24 a 48 heures).
Dans une etude prospective controlee portant sur 100 patients qui ont eu besoin
d’un catheterisme postoperatoire, les auteurs ont etabli qu’il existe un risque
definitif (6%) de bacteriurie; toutefois une infection urinaire symptomatique ne se
developpe que chez seulement 1% des patients. Les catheters de latex et de silicone
ne presentent aucun avantage, l’un par rapport a l’autre. II semble que, chez ce
groupe de patients, le risque de bacteriurie symptomatique soit tres faible quand un
systeme de drainage urinaire ferme est utilise, que l’insertion de la sonde se fait
dans des conditions de sterilite stride et que le catheter fait l’objet de soins
meticuleux suivis.

C

atheter-associated urinary tract
infection is the most common
nosocomial infection in North
America.1 The reported risk of in
fection is 5% to 10% for each day of
catheterization.2 In critically ill
medical and surgical patients an
increased morbidity and mortality
are associated with these hospitalacquired infections.34 Many patients
will require urinary catheterization
within 24 to 48 hours of operation,
and surgeons recognize the possi
bility of catheter-induced bacteri
uria. However, the incidence and

importance of the problem in this
particular group has not been stud
ied adequately. We undertook a
prospective study of bacteriuria as
sociated with short-term postopera
tive catheterization, employing
closed urinary catheter drainage
systems under near ideal conditions
of catheter insertion and ongoing
catheter care.

Patients and Methods
Randomly selected obstetric and
urologic patients requiring short
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term urinary drainage after opera
tion were catheterized in the operat
ing room, using strict sterile tech
nique. Excluded from the study
were patients whose catheter was,
or was likely to be, removed within
24 hours, those who had an exist
ing bacteriuria or could not be
catheterized with a no. 16 French
Foley catheter, and those who had
an open urinary tract (i.e., percuta
neous nephrostomy) or required
catheter irrigation. None were ex
cluded because of age, sex, medical
condition or antibiotic use. Ran
domly selected for use were either a
no. 16 French silicone catheter pre
connected to a drainage bag (sys
tem 1) or a latex catheter in a
similar closed catheter system (sys
tem 2). A sterile urine sample was
obtained and meatal culture swabs
were collected at the time of cathe
terization. Specimens were collected
daily from the catheter sample port
and from the outlet tube of the
drainage bag by an appointed study
nurse who also inspected the cathe
ter system to see that it was proper
ly connected and ascertained wheth
er the catheter had been irrigated.
Bacterial counts of 106 c fu /L or
more were considered to indicate
bacteriuria. A midstream urine spec
imen for culture was obtained with
in 12 hours of catheter removal.

Results
Of the 100 patients entered in
the study, 5 were excluded: 3 be
cause of initial bacteriuria, 1 be
cause of catheter irrigation and 1
because of incomplete culture colCJS, VOL. 32, NO. 2, MARCH 1989
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lection. Patient variables and results
for the study populations are shown
in Table I. There were six episodes
of catheter-related bacteriuria, three
in each system, for an overall infec
tion rate of 6.3%. There was no
significant difference in the rates of
bacteriuria between the two systems
(6.1% versus 6.5%). The overall
daily infection rate was 2.1% at 24
hours, 6.8% at 48 hours, 6.5% at
72 hours and 20.0% at 96 hours
(Table II).
A postoperative body tempera
ture greater than 37.5°C developed
in 29.2% of the group; however,
only one of the six bacteriuric pa
tients had a temperature greater
than 38.5°C during catheterization.
One of the six received a single
dose of antibiotic preoperatively;
the others did not. These five afeb
rile patients were asymptomatic and
showed no growth on a midstream
urine culture after removal of the
catheter, indicating spontaneous
clearing of their bacteriuria with
only catheter removal.

tems and sterile technique at time
of catheter insertion; however, the
rate of bacteriuria still increased
after 3 days of catheterization. In
our low-risk patient population
there was no significant difference
in the incidence of bacteriuria be
tween the two drainage systems.
Both employed preconnected closed
systems with antireflux mechanisms
to prevent upstream, intraluminal
bacterial contamination.
As noted, only one patient had a
significant urinary tract infection
secondary to the postoperative uri
nary catheterization. The other five
with bacteriuria had only asymp
tomatic urinary tract infections
which did not add to the cost of
care or length of hospital stay. In
fact, when the catheters were re
moved, the bacteriuria resolved
spontaneously without antibiotic
treatment. In these circumstances,
it is very unlikely that the asymp
tomatic bacteriuric episodes would
even be noted during routine post
operative hospitalization. The study
is too small to comment definitively
on the effectiveness of antibiotics in
postoperative catheter-associated
bacteriuria. In our series it did not
appear to be a major factor.
This study revealed that even

Discussion
We reduced the rate of bacteri
uria below the reported incidence by
using closed catheter drainage sys
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with closed catheter drainage sys
tems, a small but definite incidence
of bacteriuria is unavoidable in
short-term postoperative catheter
ization. However, most such cases
remain asymptomatic and will re
solve spontaneously upon removal
of the catheter. It appears therefore
that the risk of symptomatic uri
nary tract infection developing postoperatively in patients who have
sterile urine preoperatively and who
require short-term catheterization
(24 to 48 hours) is very small (1%)
provided a closed urinary drainage
system is employed under strict,
sterile conditions of catheter inser
tion and with meticulous ongoing
catheter care. There is no evident
advantage to using either a latex or
silicone catheter system.
We thank the staff of the Queen’s
University urology department and Dr.
Glen VanCott of the Kingston General
Hospital obstetrical department for
their participation in this study. We
acknowledge the logistical and editorial
support of Dimitra Baxter.
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Synovial Cyst of the Hip: an Unusual
Cause of an Inguinal Mass
Bruce B. Forster, MD;* Douglas G. Connell, MD, FRCPC;*
Charles H. Scudamore, MD, FACS, FRCS, FRCS(Edin), FRCSCt

A palpable groin mass is a common surgical problem. The authors describe the case
of a 58-year-old man who had a painless right groin mass. Initial clinical evaluation
suggested a femoral hernia. Subsequent radiologic evaluation revealed a synovial
cyst of the hip. Awareness of this anomaly will aid early diagnosis and influence
treatment.

La decouverte d’une masse palpable dans l’aine est un probleme chirurgical
frequent. Les auteurs decrivent le cas d’un homme de 58 ans porteur d’une masse
indolore a l’aine gauche. L’examen clinique initial etait evocateur d’une hernie
femorale. L’examen radiologique subsequent revela un kyste synovial de la hanche.
La connaissance de cette anomalie favorisera son diagnostic precoce et en
influencera le traitement.

masses are common clin
Inguinal
ical problems. A knowledge of
the more unusual causes of such
presentations is important to avoid
unnecessary or inappropriate sur
gery. We describe a case of a syno
vial cyst of the hip which presented
as a painless right groin swelling.
Although this is not the first such
case reported,1-4 there is no recent
discussion in the surgical literature
of the modern radiologic evaluation
of this entity.

Case Report

A 58-year-old man was referred
because of a painless right groin

f
t

1

►
►

mass, which had enlarged slowly
over 3 months. For 2 years he had
had intermittent back and right hip
pain associated with activity. There
was no history of arthritis or other
joint problems or of any other
medical problem.
On physical examination a 6 X
4-cm smooth, firm, nontender mass
was noted below the inguinal liga
ment. The mass was lateral to the
femoral artery and displaced it me
dially. No bowel sounds or bruits
were heard within the mass and the
distal pulses of the right leg were
normal. Standard x-ray films re
vealed only mild narrowing of the
right hip joint space superiorly. A
femoral hernia was suspected, but,
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because of the medial displacement
of the femoral artery, ultrasonogra
phy was done.
On ultrasonography of the right
groin (Fig. 1), a 5 X 3-cm cystic
lesion was demonstrated lateral and
deep to the femoral artery and just
anterior to the right femoral head.
The lesion did not have the appear
ance of a bowel loop, and Doppler
evaluation demonstrated no flow.
With ultrasonic guidance, 80 ml of
clear yellow fluid was aspirated
from the mass. Cytologic examina
tion of the fluid revealed a few
lymphocytes only and Gram’s stain
ing and culture gave negative re
sults. The protein concentration
was 38 g /L and glucose level 4.4
mmol/L. No crystals were seen in
the fluid.
A synovial cyst was suspected, so
15 ml of air was injected under
fluoroscopic guidance into the right

FIG. 1. Transverse sonogram of right
groin demonstrates cystic lesion (ar
rows). Femoral artery (curved open
arrow) and vein (curved closed arrow)
lie medial to cyst.
CJS, VOL. 32, NO. 2, MARCH 1989
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hip joint and computed tomography
carried out (Fig. 2). A 3.5 X 4.5-cm
cystic lesion anterior to the right
hip and lateral to the femoral ves
sels was demonstrated, with an airfluid level within it, confirming that
the cystic lesion communicated with
the right hip joint and was indeed a
synovial cyst.
Because the mass was asymptom
atic, treatment was conservative.
Follow-up 1 year later demonstrated
no change in the mass, which re
mained asymptomatic.

Discussion
Synovial cysts are protrusions of
synovial membrane caused by raised
intra-articular pressure. Cyst forma
tion in the hip, which is rare,
usually occurs through the weak
anterior zone of the joint capsule,
between the iliofemoral and pubo-

FIG. 2. Computed tomogram of pelvis
after injection of air into right hip
joint demonstrates cystic lesion with
air-fluid level within it (closed arrow)
anterior to femoral head. Femoral ar
tery (curved open arrow) and vein
(curved closed arrow) are medial and
ilipsoas muscle (open arrow) is lateral
to cyst.

134

CJS, VOL. 32, NO. 2, MARCH 1989

femoral ligaments.1 The iliopsoas
bursa lies just anterior to the hip
joint and posterior to the iliopsoas
muscle and often acts to decom
press rising intra-articular pressure.
In approximately 15% of normal
hips and 40% of hips showing ar
thritic changes, there is a communi
cation between the hip joint and the
iliopsoas bursa, allowing the bursa
to swell when there is excessive
synovial fluid production.2 This en
larged bursa or “synovial cyst” may
then dissect anteriorly between the
ilipsoas tendon and the pectineus
muscle to present as a groin mass
lateral to the femoral artery. Rarely,
it may extend retroperitoneally to
present as an intrapelvic cyst, com
pressing the bladder, ureters, sig
moid colon or cecum.3
Most patients with groin masses
and synovial cysts of the hip will
have a history of traumatic, inflam
matory (especially rheumatoid) or
degenerative joint disease suggest
ing a diagnosis. As in our case,
however, these lesions may occur
with minimal symptoms referrable
to the hip. Physical examination
should also suggest the diagnosis,
as it usually reveals a nonpulsatile
swelling inferior to the inguinal
ligament and lateral to the femoral
artery, in contrast to inguinal and
femoral hernias, which are usually
medial to the femoral vessels.
Standard x-ray Films of the hip
may reveal underlying joint disease
or may be entirely normal. Ul
trasonography should follow; it will
reveal the cystic nature of the mass,
rule out an aneurysm with Doppler
studies and allow cyst puncture to
exclude an abscess or hematoma.4

The need for more invasive studies
such as arteriography or lymphan
giography is obviated by this ap
proach. Injection of the cyst with
contrast medium under ultrasonic
control, followed by plain-film imag
ing, may show communication be
tween the cyst and the hip joint and
confirm the diagnosis. In some in
stances, however, retrograde filling
of the hip joint may not occur.3
In this event, injection of the hip
joint with air, then computed to
mography or injection of the hip
with contrast followed by plain-film
evaluation, will demonstrate the
communication.
Therapy for synovial cysts of the
hip has varied from treatment of
symptoms with rest, salicylates and
physiotherapy, to instillation of
sclerosing agents after cyst aspira
tion and surgery.3 Many patients
can be treated conservatively, which
emphasizes the importance of care
ful clinical and radiologic evalua
tion.
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Congenital Abdominal Aortic Aneurysm
D. Latter, MD; M.J. Beland, MD, FRCPC; A. Batten, MD; C.I. Tchervenkov, MD, FRCSC;
A.R.C. Dobell, MD, FACS, FRCSC
The authors report the extremely rare occurrence of a congenital abdominal aortic
aneurysm, 6 cm in diameter, found in a 1 -month-old infant. Prenatal ultrasono
graphy at 34 weeks’ gestation had shown the aneurysm, which at that time was
interpreted as a renal cyst. At operation, an 8-mm polytetrafluoroethylene tube graft
was interposed between the infrarenal aorta and the bifurcation. Cardiopulmonary
bypass facilitated operative management by permitting return of blood lost and by
maintaining body temperature.
In a review of the literature, the authors could not find any report of a neonatal
aneurysm of this magnitude. Regrettably, the cause of this true aneurysm rem ains
obscure.

Les auteurs signalent l’observation extremement rare d’un anevrisme congenital de
l’aorte abdominale, de 6 cm de diametre, chez un bebe de 1 mois. L ’echographie prenatale
a la 34e semaine de la gestation avait montre l’anevrisme, lequel avait ete confondu pour
un kyste renal. A la chirurgie une tubulure de polytetrafluoroethylene de 8 mm fut
intercalee entre l’aorte sous-renale et la bifurcation. La circulation extracorporelle a
facilite l’intervention en permettant le retour de la deperdition sanguine et le maintien de
la temperature corporelle.
A la revue de la litterature, les auteurs n’ont pu retrouve de rapport d’un anevrisme de
cette taille chez un nouveau-ne. Malheureusement, la cause de cet anevrisme vrai
demeure obscure.

bdominal aortic aneurysms are
extremely rare in infants and
children, and only one congenital
abdominal aortic aneurysm has
been described.1 We recently treated
an infant with a large abdominal
aneurysm, demonstrated on prena
tal ultrasonography. The unusual
nature of the malformation, the
surgical management of the infant
and pathological features of the
specimen are discussed in this re
port.

A

ing delivery, the infant appeared
well and fed normally. On physical
examination a large, easily palpable,
pulsatile mass, approximately 6 cm
in diameter, was noted on the left
side of the abdomen. Femoral
pulses were normal. Ultrasonogra
phy confirmed the clinical diagnosis
of a large abdominal aortic aneu
rysm and left hydronephrosis,
thought to be secondary to com
pression of the left ureter (Fig. 2).
The aorta was explored through
a midline abdominal incision. The
third part of the duodenum was
reflected off the neck of the aneu
rysm, the origin of which was below
the renal arteries. The aortic bifur
cation was normal. The inferior
mesenteric artery came off the ante
rior aspect of the aneurysm and was
ligated at its origin. The midline
incision was extended cephalad and

Case Report
A female infant, weighing 3200
g, and delivered at term by cesar
ean section, was transferred to
The Montreal Children’s Hospital at
22 days of age. The mother’s preg
nancy had been uncomplicated.
Amniocentesis had been done with
no problems at 14 weeks’ gesta
tion. Subsequent ultrasonography
showed a cystic lesion interpreted
as a left renal cyst (Fig. 1). Follow
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FIG. 1. Prenatal ultrasonography at 3 4
weeks’ gestation shows aneurysm
which was considered to be renal cyst.
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the sternum divided, permitting ex
posure and cannulation of the as
cending aorta and right atrium for
cardiopulmonary bypass, at which
time the patient was heparinized.
Cross clamps were applied below
the renal arteries and to the iliac
arteries. The aneurysm was opened
and the contained blood aspirated,
using the coronary suction device.
During the process of assessment
and repair, blood was aspirated
from the aneurysm at a rate of
approximately 10 ml/min and re
turned directly to the baby through
the aortic cannula.
From its origin, the aneurysm
extended both proximally and distally anterior to the aorta. A strip of
the anterior wall of the aneurysm
was removed for histologic study.
The aorta above the aneurysm mea
sured about 7 mm in diameter and
an 8-mm polytetrafluoroethylene
graft was interposed to bridge the
aneurysm gap, using 5-0 Prolene.
Cardiopulmonary bypass was then
applied to warm the baby from 31°
to 37°C. Protamine sulfate was
administered and the cannulas were
removed from the aorta and right
atrium. The redundant anterior an
eurysm wall was closed in front of
the polytetrafluoroethylene graft.
Postoperatively the infant did
well and at clinical examination 10
months later excellent femoral
pulses were present. Evidence of
left hydronephrosis remained, but
renal scans showed that the kidney
was functioning normally.

seen (Figs. 3 and 4). The intima was
greatly thickened and consisted of
myxoid tissue underlying endotheli

um. The media was decreased in
thickness to about one-third to onehalf that of an age-matched control

Pathological Examination
The aneurysm was saccular. The
fact that the inferior mesenteric
artery came off the anterior wall
indicates that it was a true rather
than a false aneurysm. On histolog
ic examination of the excised por
tion of the aneurysm, all compo
nents of the normal aortic wall were
136
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FIG. 2. (Top) Preoperative ultrasonography of aneurysm indicates origin of distal
aorta from aneurysm. Measurement markers are 10 mm apart. (Bottom) Ultrasonog
raphy of lower thorax and upper abdomen shows aorta entering aneurysm. A =
anterior, Cr = cranial, Ca = caudal, P = posterior, An = aneurysm, dA = distal
aorta, L = liver, H = heart, pA = proximal aorta.
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specimen from the same region of
the aorta. Elastic lamellae were
mostly well organized, regular and
'
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nonfragmented, but they were gen
erally thinner than those of the
control, with slight collagen deposi
tion in between. In one focal area (1
mm in size), the media was com
pletely deficient and the intima di
rectly underlay the adventitia. No
inflammatory infiltrate was present.
The pathological findings were
not considered diagnostic of any
specific defect. The focal complete
medial deficiency might represent a
type of incomplete dissection.

Discussion

FIG. 3. Photomicrograph of anterior
wall of aneurysm. Intima (top) shows
marked thickening due to accumula
tion of myxoid material with new blood
vessel formation (arrow). Media shows
thinning with mild fibrosis between
elastic lamellae. Entire media is shown
(Van Gieson’s elastic stain, original
magnification X 388).

Most of the abdominal aneurysms
reported in young children had an
identifiable etiology. Some were my
cotic,23 others were related to trau
ma.45 There were disorders of con
nective tissue,16-7 such as EhlersDanlos syndrome or Marfan’s syn
drome or tuberous sclerosis8 and
cases of Takayasu’s disease or cystinosis.9 We are unable to put for
ward a specific cause for this un
usual aneurysm, which was clearly

FIG. 4. Photomicrograph of aneurysm wall; lumen is at top. Media at right is
completely deficient (large arrow); to left, media has same thickness as elsewhere.
In this area, note focal collections of mucopolysaccharide, appearing as clear spaces
(curved arrow) (Masson’s trichrome stain, original magnification X 183).

present before birth. Trauma during
the amniocentesis is one possibility,
but we have discounted this on the
basis of an uncomplicated proce
dure and the fact that the aneurysm
had neither the gross or microscop
ic features of a false aneurysm.
A search of the literature dis
closed three other cases of idiopath
ic abdominal aortic aneurysms in
young children: one in a
16-month-old infant who died after
rupture of the aneurysm;10 a second
in a 7-year-old girl who survived
rupture and underwent emergency
repair.6 The media in this case was
noted to contain areas of degenera
tion with widely separated elastic
fibres, thought to be compatible
with Marfan’s syndrome. The pa
tient had no signs of the syndrome,
however, so the aneurysm was con
sidered idiopathic. The third case
was that of a neonate considered to
have a Wilms’ tumour of the left
kidney; operation led to exsangui
nating hemorrhage.11 Pathological
examination of the specimen
showed a saccular aneurysm of the
infrarenal aorta containing all layers
of the aortic wall. The intima was
thickened and the gross and micro
scopic features were similar to
those seen in our case.
Cardiopulmonary bypass may not
have been necessary in our patient,
but it relieved us of concern regard
ing blood loss during the aneurysm
repair. We did not wish simply to
discard the significant volume of
blood within the aneurysm nor that
emanating from the lumbar arteries,
as is normally done during aneu
rysm resection in adults. In our
opinion, the cardiopulmonary by
pass greatly facilitated the opera
tion and helped in returning the
infant’s body temperature to normal
at its conclusion. In fact, the ve
nous drainage line was opened only
after the aneurysm had been com
pletely repaired; the bypass until
that time was simply used to aspiCJS, VOL. 32, NO. 2, MARCH 1989
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rate intra-aortic blood and return it
to the ascending aorta. Partial car
diopulmonary bypass has been ad
vocated previously for certain highrisk aortic aneurysm repairs in
adults.12 In this report of our
unique experience in repairing a
large abdominal aortic aneurysm in
a young infant, the cardiopulmo
nary bypass provided security for
the surgical procedure.
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Thoracoabdominal aneurysms are associated with medial degenerative
disease in approximately 80% of cases. Dissection is responsible for 15%
to 20%. Median age is 65, and 70% of patients are symptomatic.
Advanced age, clamp time during repair, and chronic obstructive
pulmonary disease are the most significant causes of postoperative
morbidity and mortality. Preexisting coronary artery disease or renal
insufficiency, or both, are also significant predictors of survival
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Primary Anterior Mediastinal Tumours:
“ an Investigational Algorithm”
Guy Fradet, MD, MSc, FRCSC;* Kenneth G. Evans, MD, FRCSC;* Bill Nelems, MD, FRCSC;*
Roberta R. Miller, MD, FRCPC;t Nestor L. Muller, MD, FRCPC$
A review of 33 months’ experience with primary anterior mediastinal masses in 31
patients disclosed that in 9 (29%) the tumour was benign. Nineteen (86%) of the 22
malignant tumours and only 2 of the 9 benign tumours were symptomatic. Diagnosis
was established by histopathologic examination of a biopsy specimen or resected
tissue and serum radioimmunoassay for a-fetoprotein or human chorionic
gonadotropin, /3-subunit. The authors present an investigational algorithm, using
modern procedures, to facilitate the diagnosis of this relatively uncommon and
challenging condition.

L’etude de 31 cas de tumeurs primitives du mediastin anterieur observes au cours
d’une periode de 33 mois revele que 9 fois (29%) les tumeurs etaient benignes.
Dix-neuf (86%) des 22 tumeurs malignes et 2 des tumeurs benignes etaient
symptomatiques. Le diagnostic fut pose a l’examen histopathologique des echantillons de biopsie ou des tissus de resection, et par radio-immunodosage dans le serum
des a-foetoproteines ou des sous-unites /3 de la gonadotrophine chorionique
humaine. Les auteurs proposent un algorithme d’examens s’appuyant sur des
techniques modernes, pour faciliter le diagnostic de cette affection deroutante et
relativement rare.

A

number o f cysts and tumours
occur as primary lesions o f the

mediastinum. By surgical conven
tion, metastatic lesions, tumours
secondarily invading the mediasti
num, trachea, esophagus, heart and
great vessels are not classified as
primary mediastinal masses.1 The
anterior compartment, defined as

the area bounded by the sternum
anteriorly, the heart posteriorly, the
thoracic inlet superiorly and the
diaphragm interiorly,2 contains the
thymus, thyroid and parathyroid
glands, adipose, areolar and lym
phatic tissues. This area is the most
com m on site for mediastinal n eo
plasms.1"3 The traditional approach

From the *Department o f Surgery, fDepartment o f Pathology and fDepartm ent o f Radiology,
Vancouver General Hospital, University o f British Columbia. Vancouver, BC
Presented at the 41st annual spring meeting o f the British Columbia Surgical Society, Trail, BC,
May 4-7 , 1988
Accepted for publication Sept. 14, 1988
Reprint requests to: Dr. G. Fradet. #309
V5Z 4E5

-

C Floor. 700 West 10th Avenue. Vancouver. BC

to primary anterior mediastinal
masses is excision o f the lesion .14 5
However, with the newest ch em o
therapy regimens and im proved ra
diotherapy techniques, the m ost ef
ficacious treatment for a num ber o f
these tumours is n onsurgical.2-4-6
Better preoperative diagnosis is af
forded by com puted tom ography
and serum radioim m unoassays for
secretory products o f germ cell tu
m ou rs.13'6"8 Cervical and paraster
nal mediastinoscopy, th oracoscop y
and percutaneous fine-needle biopsy
may all provide adequate tissue for
diagnosis and are now satisfactory
alternatives to surgical excision.
W ith these new developm ents, a
more systematic diagnostic ap
proach to these tum ours may spare
patients from inappropriate surgical
procedures. W e reviewed ou r last
33 m onths’ experience with ante
rior mediastinal masses to realize
an appropriate algorithm for diag
nosing them.

Patients and Methods
Thirty-one consecutive patients
with primary anterior mediastinal
masses were admitted to V ancouver
General Hospital between March
1985 and Decem ber 1987. T um our
location was determined by chest
roentgenography and com puted to 
m ography. The diagnosis was es
tablished by h istopathologic exami-
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nation of a biopsy specimen or
resected tissue and serum radioim
munoassay for a-fetoprotein (AFP)

or human chorionic gonadotropin,
/3-subunit (bHCG). The medical re
cords of the patients were reviewed

for demographic data, clinical pre
sentation and details of their diag
nostic evaluation.

Table 1. Anterior Mediastinal Masses. Tumour Type and Associated Symptoms
Tumour type

No. (%)

Thymic
Benign (encapsulated)
Malignant
Thyroid
Benign
Malignant
Lymphatic
Malignant
Germ cell
Benign
Malignant
Mediastinitis
Benign

11
5
6
3
2
1
12
12
4
1
3
1
1

Totals
Benign
Malignant

31 (100)
9 (29)
22 (71)

Symptoms

Findings

(35)
0
5

There were 16 men and 15 wom
en, ranging in age from 15 to 79
years (mean 49 years). The age
distribution among the sexes was
similar. The relative frequency of
various tumours and associated in
cidence of symptomatic presenta
tion are shown in Table 1. Histologi
cally, 22 (71%) lesions were malig
nant and 9 (29%) benign. Nineteen
(86%) of the patients who had histo
logically malignant lesions and 2

(10)
1
1
(39)
10
(13)
0
3
(3)
1
21
2
19

Table II. Diagnostic Evaluation of Patients by Tumour Type
Age,
yr

Sex
Thymus
M
F
M
M
M
F
F
M
F
M
F
Thyroid
M
F
F
Lymphatic
M
F
F
F
M
F
F
M
M
F
F
M
Germ cell
M
M
M
M
Mediastinitis
F

Diagnosis

Symptoms

CT

AFP

bHCG

N
N
N
N
N
N
S, T, SVC
S, T, SVC
T
T-S
T. SVC

L
L

_

_

0
0
0
0

0
0
0
0
0
0
0
0
0

66
75
53
75
15
36
78
61
65

Encapsulated thymoma
Encapsulated thymoma
Encapsulated thymoma
Encapsulated thymoma
Encapsulated thymoma
Invasive thymoma
Thymic tumour of childhood
Malignant carcinoid of thymus
Squamous thymic carcinoma
Squamous thymic carcinoma
Squamous thymic carcinoma

79
56
77

Multinodular goitre
Multinodular goitre
Follicular thyroid carcinoma

N
T, SVC
T

L
L
L

20
20
27

Hodgkin's lymphoma
Hodgkin’s lymphoma
Hodgkin's lymphoma
Hodgkin’s, fibrocystic breast
Hodgkin’s lymphoma
Non-Hodgkin’s lymphoma
Non-Hodgkin’s lymphoma
Non-Hodgkin’s lymphoma
Non-Hodgkin’s lymphoma
Non-Hodgkin’s lymphoma
Non-Hodgkin’s lymphoma
Non-Hodgkin’s lymphoma

S
S
S
N
S
S
s
N
S
S.T
S,T
S

l-A
A
0
l-A
A
L
A
A
l-A
I
A
0

35

Embryonal type carcinoma
Embryonal type carcinoma
Embryonal type carcinoma

s
s
T

I
I
1

+
+

36

Benign cystic teratoma

N

1

58

Idiopathic sclerosing mediastinitis

T

1

39

45

45
51
35
56

68
60
34
55
58
19

30

0
0
0
0

l-A
I
I

I
I

0

Diagnosis
Median sternotomy
Median sternotomy
Median sternotomy
Median sternotomy
Median sternotomy
Median sternotomy
Right thoracotomy
Median sternotomy
Right thoracotomy
Left anterior mediastinotomy
Fine-needle biopsy at CT

0
0
0
0
0

n

0
0

0
0

0

n

Neck + median sternotomy

0
0

0
0

0
0
0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0
0
0

Mediastinoscopy
Mediastinoscopy
Mediastinoscopy
Mediastinoscopy
Mediastinoscopy
Manubriotomy, thymectomy
Mediastinoscopy
Mediastinoscopy
Mediastinoscopy
Left anterior mediastinotomy
Right parasternal mediastinotomy
Mediastinoscopy

+

0
0

Right anterior mediastinotomy
Median sternotomy post chemo
Fine-needle biopsy at CT, median
sternotomy post chemo
Median sternotomy

0

Manubriotomy

0

" u „y.aH"y, „ i r mem, unuu = Human cnoriomc gonaoorropin, p-suoumt, I = tnoracic, S = systemic, N = none SVC
superior vena caval obstruction, 0 = not done, L = encapsulated thyroid, thymus, I = invasive, A = lymphadenopathy, + = positive, - = negative.
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who had benign lesions were symp
tomatic.
The clinical presentation and di
agnostic evaluation of our patients
is shown in Table II. Of 11 patients
with thymic epithelial tumours, 6
were asymptomatic; 5 had totally
encapsulated thymomas and 1 had
an encapsulated thymoma with
focal microscopic capsular invasion.
The five symptomatic patients had
cytologically malignant thymic epi
thelial tumours, including three
squamous carcinomas, one malig
nant carcinoid and one thymic epi
thelial tumour of childhood.9 Symp
toms included neck discomfort, su
perior vena caval syndrome, dys
pnea, night sweats and weight loss.
No patient had myasthenia gravis
or other thymoma-associated para
neoplastic syndromes.
In the thyroid group, two pa
tients had benign multinodular
goitres, one of which gave rise to
symptoms of tracheal compression.
The third patient, with follicular
carcinoma in a mediastinal thyroid
gland, presented with goitre. None
of these patients had clinical hyper
thyroidism.
In the lymphoma group, 10 of
the 12 patients complained of symp
toms at the time of presentation;
they included night sweats, fatigue,
weight loss and fever. None had a
superior vena caval syndrome. In
two patients the diagnosis was
made during investigation of symp
toms due to an unrelated disease.
The symptoms of three patients
with malignant germ cell tumours
included dyspnea and nonspecific
chest pain at the time of diagnosis.
Our only patient with a benign
cystic teratoma was asymptomatic
when his tumour was discovered on
a routine chest film.
Finally, one patient who present
ed with a superior vena caval syn
drome of 3 months’ duration was
found to have idiopathic sclerosing
mediastinitis.

All patients had a chest x-ray film
taken and 28 had computed tomog
raphy of the chest. The diagnosis of
anterior mediastinal mass was first
made by chest x-ray in all but one
patient in whom both the chest
x-ray film and computed tomogram
showed a pulmonary density in the
right middle lobe. Following a non
diagnostic fine-needle biopsy, right
thoracotomy was done and the pa
tient was found to have a thymic
squamous cell carcinoma invading
the right-middle lobe. Computed to
mography was very useful in local
izing the mediastinal tumour in 27
of 28 cases. Five of the six patients
with thymoma underwent computed
tomography preoperatively and in
four the diagnosis was suggested.
In 10 of 12 patients with lympho
ma, computed tomography showed
mediastinal lymphadenopathy in 8
whose lymphoma was suspected at
clinical examination. The scan accu
rately localized the lesion in all
patients with thyroid tumours. Five
patients, young men between the
ages of 19 and 39 years with a
symptomatic anterior mediastinal
mass on chest x-ray film and signs
of invasion on computed tomogra
phy, had tumour marker assays
done.

Discussion
Comparison of our series with
others of primary anterior mediasti
nal masses310' 12 showed a similar
distribution of lesions in terms of
tumour type and ratio of benign to
malignant lesions. In the anterior
mediastinum, approximately onethird of the lesions are benign and
two-thirds are malignant. As previ
ously noted,11 the association of
symptoms with malignant disease
was also seen in our study.
Chest roentgenography was sen
sitive in detecting an anterior medi
astinal mass, and computed tomog

raphy, though unlikely to be more
informative, was helpful in localiz
ing the mass to the thyroid or
thymus gland. It also revealed the
extent and character of the mass,
be it homogeneous, necrotic, asso
ciated with obliteration of fat
planes, suggesting invasiveness, or
with lymphadenopathy in the mid
dle mediastinum or hilum, suggest
ing lymphoma.
Davis and colleagues3 noted the
value of computed tomography in
assessing lesions in all mediastinal
compartments. Keen and Libshitz,13
in their evaluation of computed to
mography in patients with thymic
lesions, found that it contributed
information over and above the
standard chest x-ray film in more
than 50% of cases. Additional find
ings noted in their series included
evidence of encapsulation of the
lesion, mediastinal soft-tissue inva
sion, metastases and recurrence
after therapy. Although not men
tioned in previous series, computed
tomography correctly identified me
diastinal thyroid tissue in all three
cases in our group, with no false
positive interpretations. In none of
these cases were the goitres hyper
functioning. It has been suggested14
that hyperthyroidism in a patient
with an anterior mediastinal mass
can be due to thymic lymphoid
hyperplasia, which may be treated
effectively without surgery. Lym
phoid lesions can easily be distin
guished from thyroid lesions by
computed tomography.
Serum radioimmunoassay for
AFP and bHCG is an important new
noninvasive test in some patients
with anterior mediastinal masses.
More than 90% of nonseminomatous malignant germ cell tumours
secrete either AFP or bHCG,3 and
most of them are in men under 50
years of age.15 Therefore, we agree
with the recommendation for rou
tine measurement of these two sub
stances in young men with anterior
CIS, VOL. 32, NO. 2, MARCH 1989
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mediastinal masses.3 In our series,
five patients underwent this test,
three giving a positive result; there
were no false-positive or false-nega
tive results.
With increasingly accurate preop
erative examinations, the various
methods of establishing tissue diag
nosis and the nonsurgical treatment
protocols available, a management
plan for patients with anterior medi
astinal masses is desirable. The al
gorithm we found useful is illustrat
ed in Fig. 1. Tumour encapsulation
or infiltration into the mediastinum
and the possibility that the tumour
is thymic, thyroid or vascular, can
all be assessed by computed tomog
raphy using an intravenous bolus of
contrast material. Thus, we used
the findings of this examination as
a major branching in our manage
ment schema. If the mass is found
to be of thyroid tissue or thymic
encapsulated, it is excised if clinical
ly indicated. If the lesion infiltrates
the anterior mediastinum and the
patient is male between the ages of
10 and 50 years, AFP and bHCG
assays are done. In the event of a
positive result, chemotherapy is fol

lowed by surgical removal of the
necrotic tissue.6 With a negative
result, tissue diagnosis is required
either by fine-needle biopsy, cervical
or parasternal mediastinoscopy, an
terior mediastinotomy, thoracotomy
or sternotomy, depending on the
site and size of the lesion.

Conclusions
Having demonstrated the need
for a more selective diagnostic ap
proach to the patient who has an
anterior mediastinal mass, we have
presented an investigative algo
rithm. The diagnosis of malignant
nonseminomatous germ cell tumour
can be established by tumour mark
ers (AFP, bHCG), which will be
elevated in more than 90% of cases.
Needle biopsy, mediastinoscopy and
anterior mediastinotomy will pro
vide adequate tissue for the diagno
sis of lymphoproliferative disorders.
Other lesions may need open biopsy
or excisional surgery. This diagnos
tic approach should, theoretically,
eliminate unwarranted thoracoto
mies and sternotomies.
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or topic is omitted. References are de
tailed and have been updated. The chap
ters are arranged by body systems and
cover congenital, inflammatory, degen
erative, dysplastic, neoplastic and im
munologic lesions as well as lesions of
uncertain pathogenesis. Clinicopathological correlation is discussed, but this
is not an outstanding feature of the
book. The chapters on the alimentary
tract, lymphohematopoietic system and
cardiovascular system are excellent.
The charts and tables of differential
diagnosis are extremely useful and far
surpass those found in some textbooks
on pathology of a single organ. For a
pathologist, the relative lack of gross
photographs is not a defect, but may it
be for the clinician. There are over
1400 photomicrographs. They are re
produced as non-glossy prints which is
disconcerting initially.
For the clinician, this is an excellent
reference book without numerous elec
tron photomicrographs or detailed immunocytochemistry to distract. For the
pathologist, it is a current, detailed,
everyday working book with a lucid
style.
This book is recommended as a refer
ence book for clinicians and as a basic
text for pathologists and residents in
pathology.
D.P. Hill, MD, FRCPC
Clinical Professor o f Pathology,
Faculty o f Medicine,
University o f Ottawa.
Director o f Medical Education,
Ottawa General Hospital,
501 Smyth Rd.,
Ottawa, Ont.
K1H8L6

TRAUMA, SEPSIS AND SHOCK.
THE PHYSIOLOGICAL BASIS OF
THERAPY. Edited by George H.A.
Clowes, Jr. 587 pp. Illust. Marcel Dekker, Inc., New York, 1988. $125.00
(US). ISBN 0-8247-7502-3.

This comprehensive text on the fre
quently related subjects of trauma, sep

sis and shock, is organized into six
parts: basic background, physiological,
metabolic and immunologic responses,
healing, monitoring and support. There
are 35 contributors, most of them im
mediately recognizable for their interest
and expertise in the subjects they cover.
The authors take full advantage of
diagrams, flow charts and summary
tables to present their material. For
example, one table presents the 18
preventive factors known to reduce sur
gical infections, documents the basic
reason for the efficacy of each and
provides one pertinent reference for
each. A concise summary statement
also accompanies most chapters.
Although this work is mainly con
cerned with basic mechanisms and
pathologic responses, there is a host of
material on practical stepwise manage
ment of difficult clinical problems.
Much dogma is challenged. For exam
ple, a statement with which 1 agree is
“the widespread use of fresh frozen
plasma for restoration of oncotic pres
sure, for augmentation of the immune
system in injured patients or for the
rapid correction of hypoproteinemia is
unwarranted.”
Caloric and specific substrate require
ments in normal and in acutely ill
patients are discussed and it is noted
that increasing the daily amino acid
content of intravenous solutions over
2.5 m g/kg is wasteful. Glucose calories
are preferred over fat calories in the
acutely ill and a rate per minute of 5
m g/kg is well tolerated. This translates
into a 2.5% amino acid solution provid
ing 4184 k J/L with administration of
3.5 L /d to a patient weighing 70 kg.
The amount of protein lost with injury
and sepsis cannot be eliminated by
administering protein and calories but
can be greatly reduced. The importance
of calories is emphasized in this process
which decreases gluconeogenesis by the
liver.
Excellent suggestions, based on ele
gant previous investigation, to prevent
multiple-system organ failure include
the immediate operative fixation of frac
tures which markedly reduces ventilator
time, high protein enteral nutrition,

vigorous cardiopulmonary resuscitation
and early resection of all necrotic tissue.
The precise identification of patients
likely to have a septic complication and
die as a result has been the subject of
countless projects but still eludes our
grasp. However, these investigations
have revealed many abnormalities of
cellular, humoral and general immuno
logic responses in injured patients.
Even the most skeptical now agree that
defects in host resistance are important
preliminaries to sepsis and death, even
though the precise mechanisms remain
to be defined and the predictors are not
infallible. Specific immune therapy to
treat a given defect in lymphocyte func
tion, polymorph delivery or antibody
production rate is not yet available. In
contrast, the role of antibiotics, given
either prophylactically or therapeutical
ly, is now clearly defined and is suc
cinctly presented.
The final section on monitoring and
support is particularly well done. It
contains excellent, clearly described
practical information on the detailed
management of critically ill patients.
Many problems of the critically injured
can be avoided by good initial care, and
this is repeatedly emphasized, but ex
pert care of devastating problems and
serious complications can also result in
a successful outcome.
This text emphasizes physiological
principles, background developments
and practical expert appreciation of this
knowledge in the treatment of patients
with shock and sepsis which frequently
follow trauma.
This publication can be enthusiasti
cally recommended to all physicians
dealing with the victims of trauma,
particularly to those with a special
interest in shock and sepsis.
Lloyd D. MacLean, MD, FRCSC
Coeditor,
Canadian Journal o f Surgery
Surgeon-in-Chief,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ
H3A 1A1
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